Total synthesis of elisabethin A by Leitner, Christian
 
 
 
MASTERARBEIT 
Titel der Masterarbeit 
„Total Synthesis of Elisabethin A“ 
 
Verfasser 
Leitner Christian Bsc 
angestrebter akademischer Grad 
Master of Science (MSc) 
Wien, 2012  
Studienkennzahl lt. Studienblatt: A 066 862 
Studienrichtung lt. Studienblatt: Masterstudium Chemie UG2002 
Betreuerin / Betreuer: Univ.-Prof. Dr. Johann Mulzer 
 
 
 
i 
Danksagung 
 
Ich bedanke mich bei Prof. Johann Mulzer dass er mir die Chance gegeben hat an 
so einem interessanten und komplexen Thema zu arbeiten. Weiteres möchte ich 
mich für die hervorragende Betreuung und nicht zuletzt für die großzügige finanzielle 
Unterstützung während der Masterarbeit bedanken. 
 
Mein Dank gilt auch ganz besonders meinen stets über alle maßen motivierten und 
engagierten Mitmasteranden Johannes Preindl und Simon Baldauf für ihre tolle und 
konstruktive Projektarbeit. 
 
Herzlichen dank auch an alle Kollegen und ehemaligen Kollegen im Labor (Martin 
Ariger, Jean-Baptise Farcet, Martin Himmelbauer, Jürgen Ramharter, Harald 
Weinstabl) für dutzende Hilfestellungen, hunderte von Ratschlägen, unzählige nette 
Unterhaltungen und das unglaublich tolle Arbeitsklima. 
 
Weiteres danke ich den Mitglieder der Arbeitsgruppe Mulzer (Christian Aichinger, 
Christian Dank, Martina Drescher, Rita Fürst, Maria Kauderer, Christoph Lentsch, 
Martin Lux-Amon, Harry Martin, Uwe Rinner, Sabine Schneider, Peter Siengalewicz) 
und Hammerschmidt (Fritz Hammerschmidt, Petra Malova, Renzhe Qian, Katharina 
Schiessl, Anna Wieczorek) für ihre stets motiverte und tolle zusammenarbeit. 
 
Mein Dank gilt auch den Service-Teams wie HPLC (Alina Körner), MS (Peter 
Unteregger), NMR (Hans-Peter Kählig, Sabine Felsinger) und der 
Chemikalienausgabe (Christoph Klauser) für ihre unerschütterliche Einsatzfreude 
auch bei noch so kniffligen Problemen. 
 
Ein ganz spezieller Dank gilt meiner lieben Bettina die mir hin und wieder zeigte, 
dass es auch noch was anderes als Chemie gibt. 
 
Zuletzt danke ich auch jenen denen ich nicht gedankt habe. 
 
ii 
Table of Contents 
 
1. Introduction ............................................................................................................. 1 
2. Octocoral Pseudopterogorgia Elisabethae ............................................................. 2 
2.1. Occurrence and Isolation.................................................................................. 2 
2.2. Carbon skeleton structures............................................................................... 3 
2.2.1. The serrulatane class ................................................................................. 3 
2.2.2. The amphilectane class ............................................................................. 4 
2.2.3. The elisabethane and elisapterane class ................................................... 5 
2.2.4. The colombiane, elisabane and bisnorseco-elisabethane class ................ 6 
2.3. Biosynthesis and biological activity .................................................................. 7 
2.3.1. Biosynthesis ............................................................................................... 7 
2.3.2. Biological activity ...................................................................................... 13 
3. Previously reported partial and total synthesis of P. elisabethae diterpenes ........ 14 
3.1. Total synthesis of (+)-erogorgiaene by Hoveyda et al. 2004 .......................... 14 
3.2. Total synthesis of Pseudopterosins by RajanBabu et al. 2011 ....................... 16 
3.3. Total synthesis of (+)-pseudopteroxazole by Corey et al. 2003 ...................... 20 
3.4. Total synthesis of (–)-elisabethin C by Yamada et al. 2001............................ 22 
3.5. Total synthesis of (–)-colombiasin A by Nicolaou et al. 2001 ......................... 25 
3.6 Total synthesis of (–)-elisapterosin B and (–)-colombiasin A  by Rychnovsky et 
al. 2003 ................................................................................................................. 27 
3.7 Total synthesis of (+)-elisapterosin B by Rawal et al. 2003 ............................. 30 
3.8. Partial synthesis of elisabethin A by Mulzer et al. 2003 .................................. 32 
4. Results and Discussion ........................................................................................ 36 
4.1. Retrosynthetic Analysis .................................................................................. 36 
4.2. Preliminary Studies towards elisabethin A...................................................... 37 
4.2.1. Conclusion of the Preliminary Studies ...................................................... 39 
4.3. Advanced Studies towards elisabethin A........................................................ 40 
4.3.1. Conclusion of the Advanced Studies ........................................................ 51 
4.4. New Approach to elisabethin A ...................................................................... 52 
5. Conclusion and Outlook ........................................................................................ 55 
6. Experimental Part ................................................................................................. 58 
6.1. General Information ........................................................................................ 58 
6.2. Experimental Procedures ............................................................................... 59 
iii 
7. Appendix ..............................................................................................................131 
Abstract ...................................................................................................................131 
Zusammenfassung ..................................................................................................132 
Possible Approach to Elisabethin A .........................................................................133 
7.1. List of Figures ................................................................................................135 
7.2. List of Schemes .............................................................................................135 
7.3. List of Tables .................................................................................................138 
7.4. References ....................................................................................................138 
Curriculum Vitae ......................................................................................................141 
iv 
List of Abbreviations 
 
9-BBN 9-borabicyclo[3.3.1]nonane 
Ac acetyl 
ACA asymmetric conjugate addition 
ATR attenuated total reflection 
AIBN 2,2´-azo bisisobutyronitile 
BARF sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate 
Bn benzyl 
Binol 1,1´-bi-2,2´-naphthol 
BOC t-butoxycarbonyl 
Bu (nBu) butyl 
CDI carbonyl diimidazole 
Cp cyclopentadienyl 
D.A. Diels-Alder reaction 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCM dichloromethane 
DIBAL diisobutylaluminum hydride 
DIPEA diisopropylethylamine 
DMAP N,N-4-dimethylaminopyridine 
DMF N,N-dimethylformamide 
DMP Dess-Martin periodinane 
DMS dimethyl sulfide 
DMSO dimethyl sulfoxide 
dppf 1,1´-bis(diphenylphosphino)ferrocene 
dr diastereomeric ratio 
ee enantiomeric excess 
EE ethyl acetate 
FG functional group 
GGPP geranylgeranyl diphosphate 
HRMS high resolution mass spectrometry 
IBX o-iodoxybenzoic acid 
IMDA intramolecular Diels-Alder reaction 
ImH imidazole 
v 
IPC isopinocamphenyl 
IR infrared spectroscopy 
KHMDS potassium bis(trimethylsilyl)amide 
LAH lithium aluminum hydride 
LDA lithium diisopropylamide 
LHMDS lithium bis(trimethylsilyl)amide 
mCPBA meta chloroperbenzoic acid 
MOM methoxymethyl 
Ms mesyl (methansulfonyl) 
MS mass spectrometry 
NBS N-bromosuccinimide 
NHK Nozaki-Hiyama-Kishi 
NHMDS sodium bis(trimethylsilyl)amide 
NMO N-methylmorpholine oxide 
NMR nuclear magnetic resonance 
Nu nucleophile 
PCC pyridinium chlorochromate 
PDC pyridinium dichromate 
PIDA phenyliodonium diacetate 
Piv pivaloyl 
py. pyridine 
TBAF tetra-n-butylammonium fluoride 
TBDPS t-dibutyldiphenylsilyl 
TBS t-dibutyldimethylsilyl 
TES triethylsilyl 
Tf trifluoromethanesulfonyl 
TFA trifluoracetic acid 
THF tetrahydrofuran 
TIPS triisopropylsilyl 
TMP 2,2,6,6-tetramethylpiperidine 
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TPAP tetra-n-propylammonium perruthenate 
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1. Introduction 
 
Sea whips, sea fangs, sea fans, and sea plumes of the genus Pseudopterogorgia are 
remarkable dwellers of the Caribbean reefs. During the last two decades many 
ambitious efforts have been committed to the exploration of the natural product 
chemistry of the West Indian gorgonian octocoral Pseudopterogorgia elisabethae 
(Bayer, 1961).1 These chemical studies have shown that this species possesses an 
astounding source of a large variety of secondary metabolites, mainly diterpenoids, 
sesquiterpenoids, and steroids.2 The compounds are of current interest as a source 
of unique metabolites due to their interesting biological activities.3 Some 
pseudopterosins for example are potent anti-inflammatory and analgesic compounds 
that have been licensed for medical use as potential anti-inflammatory drugs. 
Investigations from the Rodríguez group on the chemical constituents of a specimen 
of Pseudopterogorgia elisabethae (Bayer) collected near San Andrés Island, 
Colombia, resulted in the isolation of many structurally interesting diterpenoids. Some 
of these components are elisabethin A, elisabanolide and elisapterosin, possessing 
the uncommon elisabethane, elisabane and elisapterane carbon skeleton 
respectively. These natural products stood out having the most complex structures.4 
Also rearranged terpenoids of the nor-sandresane skeletal class in addition to 
amphilectane- and serrulatane-based diterpenes are found.5,6,7 Some of these 
exciting natural products are presented on the following pages. 
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2. Octocoral Pseudopterogorgia Elisabethae 
 
 
Figure 1: Pseudopterogorgia Elisabethae 
 
2.1. Occurrence and Isolation 
 
The Caribbean sea whip Pseudopterogorgia Elisabethae (Figure 1) was discovered 
in the reefs of the West Indian region, the Bahamas and the Florida Keys.8 The 
natural habitat of this octocoral is generally on deeper reef communities as well as on 
fore reef zones. The systematic classification within the animal kingdom is: phylum 
Cnidaria, class Anthozoa, order Gorgonacea, family Gorgoniidae, genus 
Pseudopterogorgia, species Pseudopterogorgia Elisabethae.  
 
 
Figure 2: Map of the Caribbean Sea 
 
Rodríguez and coworkers collected a small sample of this animal in deep waters 
near San Andrés Island (Columbia) for chemical investigations (Figure 2). The freshly 
collected animals (1.0 kg) were sun dried and stored frozen. The dried P. elisabethae 
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was extracted subsequently with MeOH/CHCl3 (1:1). The organic suspension was 
filtrated and the solvent was removed under reduced pressure. The residue was 
partitioned between hexane and water. The hexane layer was separated and 
concentrated in vacuo to an oil. A portion was dissolved in a small volume of toluene 
fractionated by successive size exclusion chromatography (Bio-Beads SX-3 in 
toluene), silica gel chromatography, and HPLC. Thereby it was possible to explore 
the natural product chemistry of P. elisabethae to a concentration range of 
0.0001 wt.% according to the dry weight.9 
 
2.2. Carbon skeleton structures 
 
This gorgonian species alone is responsible for the production of over twenty 
different skeletal classes of terpenes with unique substitution patterns and 
functionalities. This chapter gives a short overview about several carbon skeleton 
classes of some diterpenes isolated from P. elisabethae. All of the following 
compounds were determined by spectral analyses and if possible by X-ray 
crystallographic analysis. 
 
2.2.1. The serrulatane class 
 
 
Figure 3: Compounds of the serrulatane class 
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Figure 3 shows some compounds of the serrulatane class. This carbon skeleton 
class is structurally simple. It´s features are the two annulated cyclohexane rings with 
one methyl group on each ring and the branched eight-carbon side chain at position 
3. Elisabethatriene (2) is the simplest compound of this family. Compound 3 is a 
higher oxygenated serrulatane and possesses a full substituted quinone system. 
Compound 4 is one of the more common molecules. Structural features of this 
metabolite are the quinone system and the allylic hydroxyl group on the side chain. It 
was first isolated by Fenical and coworkers.10 Elisabethadienol (5) is a more recent 
metabolite and was found by Rodríguez and coworkers.9 A good known serrulatane 
is seco-pseudopterosin A-D aglycon (6). This natural product exhibits an aromatic 
ring with two hydroxy groups. Glycosylation of the hydroxy groups generates the 
corresponding seco-pseudopterosins. 
 
2.2.2. The amphilectane class 
 
 
Figure 4: Compounds of the amphilectane class 
 
The amphilectane class is structurally related to the serrulatane class. The only 
difference in the amphilectane class is the additional C-C bond between the C1 and 
C13 carbon atom which closes the third ring. Structural features of this class are the 
three annulated six membered rings, the three methyl groups on each ring and the 
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very common isobutenyl sidechain. Compound 8 was first isolated by Fenical and 
coworkers and is a possible intermediate in the pseudopterosin synthesis.10 
Compound 9 is pseudopterosin A-D aglycon. The indices belong to the different 
sugar moieties (D-xylose and their derivatives) at position eight. Noteworthy is that 
pseudopterosin K,L aglycon (12), the enantiomer of pseudopterosin A-D aglycon (9) 
was isolated from the same P. elisabethae species collected by the Bahamas 
Islands. Apparently both enantiomers have a biological function. Elisabathin A (10) 
and B (11) are unique among the amphilectane class because they possess an 
unusually high aromatic conjugation. They were discovered a little bit later based on 
the low concentration in the extracts by Rodríguez and coworkers (Figure 4).6 
 
2.2.3. The elisabethane and elisapterane class 
 
 
Figure 5: Compounds of the elisabethane class and the elisapterane class 
 
Like the amphilectane class, the elisabethane class also possesses three rings. But 
in this case there are two annulated six membered rings and one five membered ring 
annulated to a six membered ring. Thus, a quaternary carbon atom is generated at 
position 2. Additionally, the isobutenyl side chain is still present. Two examples of this 
class are elisabethin A (14) and D (15). The difference between the two compounds 
is the hydroxy group of elisabethin B (18) at position 7 (Figure 5). 
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The next more complex carbon skeleton class is the elisapterane class. The only 
difference of these two carbon classes is the additional carbon bond between C10 
and C14 in the elisapterane structure. Hence, a new five membered ring is 
generated. Structural features are the bicyclo[3.2.1]octane system and the five and 
six membered rings annulated to each other and to this bicycle. Still present are the 
three methyl groups on the different rings. The isobutenyl side chain has now 
changed into an isopropenyl moiety. Furthermore, there are two quaternary carbon 
atoms at positions 2 and 10 in the skeleton structure. Examples of this carbon 
skeleton class are elisapterosin A (17) and B (18). Noteworthy is that elisapterosin A 
(17) is the more oxidized compound and possesses an additional five membered 
ring, which generates a hemiacetal moiety at position 9. 
 
2.2.4. The colombiane, elisabane and bisnorseco-elisabethane class 
 
 
Figure 6: Compounds of the colombiane, elisabane and bisnorseco-elisabethane class 
 
Another intricate carbon class is the colombiane family. This carbon skeleton class is 
closely related to the elisabethane class. The only difference is the additional carbon 
bond between C7 and C16, which concurrently builds up the fourth ring. Structural 
features are the three six membered rings and the five membered ring which are 
annulated to each other. Additionally, each ring has a methyl substituent. An example 
of this class is colombiasin A (22). It was fist isolated by Rodríguez and coworkers.11 
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The next carbon skeleton class is the elisabane class. It is actually a nor-diterpene 
because it possesses only 19 carbon atoms. A closer look on this carbon skeleton 
reveals that carbon atom 8, between C7 and C9, is missing. This leads to the 
assumption that the elisabane class is a derivative of the elisapterane class. 
Structural features of this family are the two annulated five membered rings and one 
six membered ring annulated to a five membered ring. Also the two quaternary 
carbon atoms and the isopropyl side chain are worth mentioning. Elisabanolide (23) 
is one example of this terpenoid class. 
The last carbon skeleton class in Figure 6 is also not a diterpene. It is a bisnor-
diterpene, which means it possesses only 18 carbon atoms. It is a further derivative 
of the elisabethane class. Structural features are the annulated five and six 
membered ring, again the isobutenyl side chain and the propyl side chain. Moreover, 
the molecule holds one quaternary carbon atom and a methyl group on each ring. An 
example of this carbon family is Elisabethin C (24). 
 
2.3. Biosynthesis and biological activity 
 
2.3.1. Biosynthesis 
 
 
Scheme 1: Diterpene cyclase to elisabethatriene (2) 
 
The biosynthesis starts from geranylgeranyl diphosphate (25) (GGPP). GGPP is a 
diterpene from the terpene biosynthesis called mevalonate pathway12,13. A closer 
look at GGPP reveals that each carbon atom that is required for the diterpene 
skeleton is still present. Hence, just functional group manipulations, insertions and 
cyclizations reactions are outstanding. The first step in the biosynthesis is a 
cyclisation of GGPP catalyzed by the enzyme elisabethatriene cyclase. This terpene 
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cyclase is one of the key enzymes in the biosynthesis, as these generally assemble 
the entire carbon skeleton in a single step to elisabethatriene (2) (Scheme 1). 
Elisabethatriene cyclase is a monomer with a molecular mass of 47 kDa. This 
molecular mass is quite different compared to terrestrial diterpene cyclases (e.g. 
taxydiene synthase, kaurene synthases A and B have molecular masses of approx. 
80 kDa). This suggests that the structure of the elisabethatriene cyclase is might be 
different from those isolated from terrestrial organisms. The enzyme was first isolated 
and characterized by Kohl and coworkers.14 
 
 
Scheme 2: Possible biosynthetic pathway for the elisabethatriene (2) synthesis 
 
One possible mechanism for the formation of elisabethatriene (2) from 
geranylgeranyl diphosphate (25) is described in Scheme 2. The first step is the loss 
of the pyrophosphate group from GGPP. The stabilized allylic cation undergoes 
isomerization from E to Z to intermediate 27. The double bond between C3 and C11 
attacks the allylic cation to form a ten membered ring and a tertiary cation 
respectively. Subsequently two hydride shifts occur to introduce the stereochemistry 
at position C3 and C11. After attack of the C6-C7 double bond to the allylic cation, 
the ten membered ring is divided in two annulated six membered rings. Two further 
hydride shifts initiates the stereochemistry at position C6 and C7. Subsequently 
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abstraction of a proton at C18 generates the third double bond to elisabethatriene 
(2). 
 
 
Scheme 3: Biosynthetic pathway to seco-pseudopterosin and pseudopterosin 
 
In the biosynthetic analysis outlined in Scheme 3, pseudopterosins co-occur with 
seco-pseudopterosins, suggesting that these two classes of diterpenes are produced 
through a single cyclase product. 15 Next step in the biosynthesis is an aromatization 
to erogorgiaene (31).16 This intermediate can be hydroxylated ortho or meta to the 
methyl group to provide compound 32 or 33 respectively. A second hydroxylation in 
ortho-position to the existing hydroxy group of compound 32 or 33 respectively 
affords seco-pseudopterosin A-D aglycon (6). Hydroxylation of compound 33 at the 
para-position delivers intermediate 34. The next postulated step is oxidation of 
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intermediate 34 to compound 35. A subsequent ring closure forms compound 8. A 
following reduction with elimination of water yields pseudopterosin A-D aglycon (9). 
Additional installation of a sugar moiety at aglycon 6 and 9 delivers the 
corresponding seco-pseudopterosin and pseudopterosin.15 
 
 
Scheme 4: Biosynthetic pathway to elisabethin A (14) and D (15) 
 
The possible biosynthesis of elisabethin A (14) and D (15) starts with an allylic 
oxidation at the side chain of quinone 35 to compound 4 (Scheme 4).The generated 
hydroxy group is subsequently phosphorylated to compound 36. The following step is 
a nucleophilic attack in a Michael fashion of a hydride or water at the quinone system 
to intermediate 37 or 38 respectively. The resulting enol intermediate immediately 
substitutes the phosphate to build up the five membered ring of elisabethin A (14) or 
D (15). 
These two elisabethin metabolites 14 and 15 offer the way to other natural products. 
Based on this biosynthetic proposal, elisabethin A (14) and D (15) are two key 
intermediates to generate other metabolites on different pathways. Possible 
metabolites of elisabethin D (15) are elisapterosin A (17), elisabanolide (23) and 
elisabethin C (24) (Scheme 5). The synthesis of elisapterosin A (17) starts with an 
allylic oxidation and subsequent phosphorylation of elisabethin D (15) at the 
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isobutenyl side chain to intermediate 39. The phosphorylated hydroxy group acts 
again as a leaving group to enable the ring closure to compound 40. Another 
possibility is the direct oxidation of the enedione system to a carbocation 
intermediate, at position 10, which is immediately attacked by the isobutenyl double 
bond to compound 40. Addition of water to the isopropenyl double bond generates a 
tertiary alcohol, which attacks the carbonyl at position 9 to build up a five membered 
hemi acetal ring to complete the biosynthesis of elisapterosin A (17). 
 
 
Scheme 5: Biosynthetic pathway of elisabethin C (24), elisapterosin A (17) and elisabanolide (23) 
 
The biosynthesis of elisabanolide (23) demands cleavage of the oxidized six 
membered ring and the carbon atom at position 8 must be removed. This suggests 
an oxidative bond cleavage between position 8 and 9 to generate a five membered 
12 
lactone and a carboxylic acid. A second oxidative fragmentation between position 7 
and 8 release carbon dioxide and water to generate a ketone moiety at the six 
membered ring to yield the nor-diterpene elisabanolide (23).17 
The biosynthesis of elisabethin C (24) also requires a cleavage of the oxidized six 
membered ring and a removal of the carbon atom at position 9. Thus, the reaction 
mechanism should be quite similar to the elisabanolide pathway. The first step is 
again an oxidative cleavage of the carbon bond between position 8 and 9 to 
intermediate 42. A second oxidative cleavage between position 7 and 8, releases 
bicarbonate to generate the ketone functionality at the remaining six membered ring. 
The decarboxylation reaction free up the second carbon atom completes the 
biosynthesis of the bisnor-diterpene elisabethin C (24).4 
 
 
Scheme 6: Biosynthetic pathway of elisapterosin B (18) and colombiasin A (22) 
 
The biosynthetic pathway of elisapterosin B (18) out of elisabethin A (14) is 
suggested quite similar to the biosynthesis of elisapterosin A (17). 18 Scheme 6 
shows the direct oxidation of the enedione system to a carbocation intermediate, at 
position 10, which is instantly attacked by the isobutenyl double bond to elisapterosin 
B (18). But also an allylic oxidation at the isobutenyl side chain to the primary alcohol 
followed by phosphorylation and subsequently substitution via an intramolecular aldol 
reaction to elisapterosin B (18) is possible. A nucleophilic attack of the enol 
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functionality at the isopropylene double bond generates a six membered ring and 
simultaneously fragment the five membered ring, which was build up in the previous 
step, to colombiasin A (22). 
 
2.3.2. Biological activity 
 
Some seco-pseudopterosins and pseudopterosins of Pseudopterogorgia elisabethae 
collected from several locations throughout the Caribbean region exhibits strong anti-
inflammatory and analgesic activity that exceed the potencies of existing drugs such 
as indomethacin.19 Unprocessed pseudopterosin extracts currently being used as an 
additive to prevent irritation caused by exposure to sun or chemicals of the skin. 20 
 
Some compounds of the serrulatane, amphilectane, elisabethane and elisapterane 
class show in vitro antituberculosis activity against Myobacterium tuberculosis 
H37Rv. Especially erogorgiaene (31), elisapterosin B (18) and pseudopteroxazole 
(44) (Figure 7) have a strong growth inhibitory activity against M. tuberculosis (96%, 
79% and 97% respectively). Also Elisabanolide (23) and Elisabethin C (24) possess 
a moderate inhibitory activity of 39% and 42% against M. tuberculosis.21 
 
 
Figure 7: Pseudopteroxazole (44) 
 
Several diterpenes of P. elisabethae indicate also cancer cell cytotoxicity. For 
example, Elisabethin D (15) show significant in vitro cell toxicity with concentrations 
of 10-5 M, which reveal significant differential responses at the GI50 level from all the 
renal, CNS, and leukemia cancer cell lines.22 Also elisabathin A (10) shows weak in 
vitro cancer cell toxicity. 
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3. Previously reported partial and total synthesis of P. elisabethae diterpenes 
 
3.1. Total synthesis of (+)-erogorgiaene by Hoveyda et al. 2004 
 
Hoveyda´s retrosynthetic strategy based on a copper catalyzed asymmetric 
conjugate addition (ACA) of a methyl group to an -unsaturated ketone. The side 
chain was installed via cross metathesis with methyl vinyl ketone. The ring closing 
was accomplished through an enyne metathesis with the same catalyst used in the 
cross metathesis. Functionalization of the commercially available aromatic compound 
48 was done under standard palladium coupling conditions (Scheme 7). 
 
 
Scheme 7: Retrosynthetic analysis of (+)-erogorgiaene (31) 
 
The total synthesis starts with a Heck coupling reaction of commercially available 
aromatic compound 48 under Jeffery conditions to afford -unsaturated ketone 49 
(Scheme 8).23 Asymmetric conjugate addition of Me2Zn with Cu(OTf)2 and ligand 50 
delivers -methyl ketone 51. The next step is a Stille coupling reaction to alkyne 52. 
Enolization with LiTMP gives the kinetically favored TMS enol ether with a 
regioselectivity of >25:1. Treatment with MeLi and Tf2NPh delivers the enol triflate 
53.24 Conversion of the enol triflate into a double bond was accomplished by a 
palladium catalyzed reduction.25 Cleavage of the TMS group with K2CO3 generates 
the enyne precursor 47. Treatment of compound 47 with Ru-catalyst 54 (Scheme 9) 
affords dihydronaphthalene 46 after a ring closing enyne methathesis reaction. The 
15 
generated exomethylene group is converted into an -unsaturated methyl ketone 
via cross metathesis with Ru-catalyst 54 and methyl vinyl ketone to enone 55. The 
next step is a diastereoselective conjugate addition of Me2Zn with Cu(OTf)2 and 
ligand 50 (Scheme 9) to intermediate 56. 
 
 
Scheme 8: Total synthesis of (+)-erogorgiaene (31) part 1 
 
Direct hydrogenation of compound 56 under various conditions first affords the 
undesired diastereoisomer. Thus, the ketone moiety must be reduced with NaBH4 to 
the secondary alcohol. Hydrogenation of the double bond with lithium in liquid 
ammonia and subsequent oxidation at the secondary alcohol with DMP delivers 
compound 45 with the desired stereochemistry. Next step is a transformation of the 
ketone moiety into the kinetically favored TMS enol ether with LDA and TMS-Cl. 
Oxidative cleavage of the TMS enol ether with ozone and subsequent treatment with 
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DMS delivers the aldehyde intermediate. Reduction of the aldehyde generates the 
primary alcohol 57. The alcohol is transformed into an iodide under Appel conditions. 
Nucleophilic substitution of the alkyl iodide with an isobutenyl cuprate affords the 
natural product erogorgiaene (31). 
 
 
Scheme 9: Total synthesis of (+)-erogorgiaene (31) part 2 
 
In summary, the enantioselective total synthesis of erogorgiaene (31) has been 
reported with an overall yield of 4% in 18 steps starting from commercially available 
aromatic compound (48).26 
 
3.2. Total synthesis of Pseudopterosins by RajanBabu et al. 2011 
 
In contrast to some other total synthesis of pseudopterosins, RajanBabu used an 
aromatic compound instead of optically pure starting material for his synthesis.27,28,29 
He initially synthesized the pseudopterosin core and installed the isobutenyl side 
chain afterwards. Thus, he could control the stereochemistry of the isobutenyl side 
chain via an asymmetric hydrovinylation reaction. Furthermore he was able to 
synthesize the aglycon of pseudopterosin A-F and G-J only by changing a few steps. 
Moreover he was able to invert all stereocenters introduced by hydrovinylation to 
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synthesize the aglycon of pseudopterosin K and L. Other key steps are the two ring 
closing reactions through an intramolecular Friedel-Crafts acylation of the aromatic 
ring (Scheme 10). 
 
 
Scheme 10: Retrosynthetic analysis of pseudopterosin aglycons A-J 
 
The synthesis starts with a Ni-catalyzed asymmetric hydrovinylation of compound 63, 
using ligand 64 (Figure 8). This reaction delivers intermediate 65 with the desired 
stereochemistry in quantitative yield (Scheme 11). Starting material 63 is available 
from 2,3-dimethoxy toluene via regioselective formylation with t-BuLi and DMF 
followed by Wittig olefination. 
 
 
Figure 8: Ligands for the Ni-catalyzed asymmetric hydrovinylation 
 
The next step is a regioselective hydroboration with 9-BBN and subsequent oxidation 
to the primary alcohol.30 Substitution of the alcohol under Appel conditions delivers 
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the alkyl iodide. A second displacement with sodium cyanide generates the primary 
cyanide 62. Hydrolysis of cyanide 62 and subsequent treatment with oxalyl chloride 
affords the acid chloride. Cyclization under Friedel-Crafts conditions delivers 
tetralone 66. Treatment of the ketone with KHMDS and PhNTf2 generates the enol 
triflate. Stille coupling of the enol triflate with tributyl vinyl stannane affords diene 
61.31 A second Ni-catalyzed asymmetric hydrovinylation using ligand 67 provides the 
second stereogenic center in excellent diastereoselectivity.  
 
 
Scheme 11: Total synthesis of pseudopterosin aglycons A-J part 1 
 
In the next step the exomethylene group is transformed into a primary alcohol by 
treatment with 9-BBN and hydrogen peroxide. The remaining double bond is 
hydrogenated with lithium in liquid ammonia to give alcohol 69 with a diastereomeric 
ratio of 20:1.26 Oxidation of the primary alcohol under Swern conditions affords 
aldehyde 60. Pinnick oxidation of the aldehyde and treatment with oxalyl chloride 
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provides the acid chloride. A second Friedel-Crafts acylation reaction closes the third 
ring to key intermediate 70. Out of compound 70 both series of aglycons, 
pseudopterosin A-F (9) and G-J (58) respectively are available. The first series of 
pseudopterosin aglycons A-F (9) are synthesized by transformation of the ketone into 
an epoxide moiety (Scheme 12). Subsequent opening of the epoxide with boron 
trifluoride affords the aldehyde. Olefination with an isopropenyl Wittig reagent and 
cleavage of the methoxy ether with TMS-I delivers pseudopterosin aglycon A-F (9). 
This endgame was done by Corey and coworkers. 32 
 
 
Scheme 12: Total synthesis of pseudopterosin aglycons A-J part 2 
 
The second series of pseudopterosin aglycons G-J (58) are synthesized by reduction 
of the ketone to the alcohol. Elimination of the alcohol under acidic conditions 
delivers compound 59. A third Ni-catalyzed asymmetric hydrovinylation, using ligand 
67, provides the last stereogenic center in excellent yield and diastereoselectivity. 
Oxidative cleavage of the double bond and work up with DMS generates the 
aldehyde moiety. Olefination of the aldehyde with an isopropenyl Wittig reagent and 
cleavage of the methoxy ether with sodium thioethanolate provides pseudopterosin 
aglycon G-J (58). In summary, the synthesis is due to the asymmetric hydrovinylation 
reaction very flexible. Based on this synthetic tool it is possible to synthesize all 
pseudopterosin aglycons.33 
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3.3. Total synthesis of (+)-pseudopteroxazole by Corey et al. 2003 
 
Corey’s synthesis started from an optically pure (S)-(–)-limonene derivative which 
includes three out of four stereogenic centers of the final molecule. Thus, an 
important key step in the retrosynthetic analysis was the stereocontrolled ring closing 
reaction between position 1 and 13. A second key step was a modified Wolff-
Semmler reaction to build up the aromatic ring (Scheme 13). 
 
 
Scheme 13: Retrosynthetic analysis of (+)-pseudopteroxazole (44) 
 
The synthesis outlined in Scheme 14 starts with the diol mixture 75 which can be 
obtained in almost quantitative yield from (S)-(–)-limonene by cyclic hydroboration 
and alkaline peroxide oxidation.34 The nearly 1:1 mixture of diastereomers underwent 
selective oxidation with sodium hypochlorite at position to the corresponding hydroxy 
ketones.35 Exposure of this mixture to isopropenyl acetate and Amano PS lipase as 
catalyst generates in selective acetylation the (8R)-alcohol 76 and the acetylated 
(8S)-ketone. Next step is the protection of the primary alcohol with TBDPS-Cl. Kinetic 
deprotonation with LDA and trapping of the enol with TMS-Cl provides the TMS enol 
ether. A Mukaiyama-Michael reaction with tin tetrachloride and ,-unsaturated 
ketone delivers compound 74 in a 1:1 mixture of diastereomers. Cyclization of the 
1,5-diketone with potassium hydroxide and subsequent treatment with thionyl 
chloride in pyridine affords bicyclic ketone 77. Hydroxylamine hydrochloride and 
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pivaloyl chloride in toluene delivers the O-pivaloyl protected oxime 78. The next step 
is a modified Wolff-Semmler reaction with acetyl chloride in toluene to yield product 
73. Hydrogenolysis of the benzyl ether followed by cyclization with 
carbonyldiimidazole and cleavage of the acetate group with sodium bicarbonate 
delivers intermediate 79.  
 
 
Scheme 14: Total synthesis of (+)-pseudopteroxazole (44) 
 
Next steps are cleavage of the TBDPS group with hydrofluoric acid-pyridine complex 
and mild oxidation with tetrapropylammonium perruthenate to the aldehyde. A 
following Wittig-Vedejes E-selective olefination affords the cyclization precursor 72.36 
Treatment of compound 72 with methane sulfonic acid in acetic acid generates an 
allylic cation which undergoes an aromatic electrophilic substitution reaction. Hence, 
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the third six membered ring is closed to give a 4:1 mixture of diastereomers favoring 
the desired tetracycle. Next steps are acetylation of the free NH group with di-tert-
butyl dicarbonate, cleavage of the carbamate group with excess of methylmagnesium 
bromide and subsequent treatment of the dianion with a mixture of 
triethylorthoformate and trifluoracetic acid to provide the natural product 
pseudopteroxazole (44). 
In summary, the enantioselective total synthesis of (+)-pseudopteroxazole (44) has 
been reported with an overall yield of approx. 2% in 20 steps starting from 
commercially available (S)-(–)-limonene.37 
 
3.4. Total synthesis of (–)-elisabethin C by Yamada et al. 2001 
 
A key step in Yamadas retrosynthetic strategy was an intramolecular Dieckmann 
condensation to build up the five membered ring. Hence, he generated a spirolactone 
to introduce the correct stereochemistry for the later isobutenyl side chain. Special 
attention in the synthesis requires the quaternary carbon atom. Yamada generated 
this quaternary center in a very early stage through a double aldol reaction. 
Therefore, he used (+)-carvone to get an acceptable stereoinduction for the 
introduced side chains (Scheme 15). 
 
 
Scheme 15: Retrosynthetic analysis of (–)-elisabethin C (24) 
 
The synthesis starts (Scheme 16) with an aldol reaction, using LDA and prenyl 
bromide to introduce the first side chain. A second aldol reaction with LDA and 
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formaldehyde in THF generates the quaternary stereocenter of compound 84 in a 9:1 
mixture of diastereomers. Reduction of the double bond and the ketone moiety with 
lithium in liquid ammonia, followed by protection of the primary alcohol with TBS-Cl 
and a second protection of the secondary alcohol with MOMCl provides intermediate 
85 as a single product. Regio- and stereoselective hydroboration of the 
exomethylene double bond using 9-BBN and subsequently oxidation with hydro 
peroxide generates the primary alcohol.38  
 
 
Scheme 16: Total synthesis of (-)-elisabethin C (24) part 1 
 
Protection of the primary alcohol with pivaloyl chloride and cleavage of the TBS 
group with tetrabutylammonium fluoride affords alcohol 82. Ozonolysis of the 
remaining double bond and work up with dimethyl sulfide provides a five membered 
lactol. Oxidation of the lactol to the lactone with PDC, cleavage of the MOM group 
with hydrochloric acid and subsequent oxidation with PCC delivers spirolactone 86. 
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Epimerization of the methyl group alpha to the ketone moiety with potassium 
carbonate affords intermediate 87 in a 10:1 mixture favoring the desired 
diastereomer. Next step is a transformation of the ketone moiety to an exomethylene 
double bond with TMSCH2Li followed by treatment with hydrochloric acid.
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Deprotection of the pivaloyl group with sodium methanolate in methanol affords the 
primary alcohol. Oxidation of this alcohol under Jones conditions and subsequent 
esterification of the carboxylic acid with methyl iodide and potassium carbonate 
generates methyl ester 81. Enolization of the spirolactone using sodium hydride and 
15-crown-5 initiates the Dieckmann condensation to the tricyclic intermediate 88 as a 
single product. It is noteworthy that the methyl group at the five membered ring 
epimerizes under these conditions concomitantly to the desired stereomer. Next 
steps are reduction of the ketone to an alcohol with sodium borohydride, 
transformation of the alcohol into a xanthate using carbon disulfide, NaH and methyl 
iodide followed by radical reduction of the xanthate with tributyltin hydride.40 
Ozonolysis of the double bond and reductive work up with sodium borohydride 
followed by protection of the secondary alcohol with TES-Cl provides compound 80. 
 
 
Scheme 17: Total synthesis of (-)-elisabethin C (24) part 2 
 
Reduction of the lactone to the lactol with DIBAL and subsequent opening of the 
lactol with a Wittig reagent generates the isobutenyl side chain. Oxidation of the 
alcohol with Dess-Martin periodinane affords the aldehyde 89.41 Introduction of the 
second side chain with etyhlmagnesium bromide, cleavage of the TES group with 
tetrabutylammonium fluoride and oxidation of the two alcohol groups with DMP 
provides the natural compound elisabethin C (24) (Scheme 17). In summary, the 
enantioselective synthesis of (–)-elisabethin C (24) has been reported with an overall 
yield of approx. 4% in 29 steps starting from commercially available (+)-carvone.42 
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3.5. Total synthesis of (–)-colombiasin A by Nicolaou et al. 2001 
 
Colombiasin A (22) consists of three six membered rings and one five membered 
ring, which are annulated to each other. This ring arrangement generates two vicinal 
quaternary carbon atoms in the center of the molecule. Nicolaou’s retrosynthetic 
strategy is based on an intramolecular Diels-Alder reaction, which generated two 
rings and the two quaternary carbon atoms in one step. A further key step was the 
side chain introduction via a palladium catalyzed Claisen-type rearrangement. The 
aromatic ring was used as a kind of protecting group for the quinone system. 
Moreover, he utilized a second Diels-Alder reaction and a chiral catalyst to get 
optically pure material (Scheme 18).  
 
 
Scheme 18: Retrosynthetic analysis of (–)-colombiasin A (22) 
 
The synthesis starts (Scheme 19) with an asymmetric Diels-Alder reaction with diene 
95 and quinone 94 in the presence of the Mikami catalyst for chiral induction.43 
Quinone 94 is prepared by ortho-methylation of 1,2,4-trimethoxybenzene followed by 
oxidative cleavage of the methoxy groups with AgO and nitric acid.44,45 Aromatization 
by a double enolization of the ketones with potassium carbonate and subsequent 
methylation with methyl iodide delivers the aromatic system. Cleavage of the TBS 
ether with trifluoracetic acid affords the bicyclic ketone 93. Enolization of the ketone 
with LHMDS and treatment with crotyl chloroformate delivers compound 92.46 The 
next step is a palladium catalyzed Claisen-type rearrangement to introduce the side 
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chain in -position to the ketone. This reaction generates two products in a 2.4:1 
mixture. The mixture is reduced with sodium borohydride followed by protection with 
TBSOTf to compounds 97 and 98. Dihydroxylation with osmium tetroxide and 
subsequent cleavage of the diol with sodium periodate delivers the aldehyde 
moiety.47 Epimerization in -position to the aldehyde with sodium methanolate 
provides aldehyde 99 in a 1.1:1 mixture of diastereomers favoring the desired one. 
 
 
Scheme 19: Total synthesis of (–)-colombiasin A (22) part 1 
 
Next steps are Wittig olefination, followed by hydroboration with diborane and 
oxidation with hydrogen peroxide to a primary alcohol. Oxidation of the primary 
alcohol with PCC provides compound 100. A further Wittig reaction affords 
intermediate 101 in a 3:1 mixture of double bond isomers. Protection of the diene 
system by treatment with sulfur dioxide delivers a cyclic sulfone.48 Cleavage of two 
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methoxy groups and the TBS group with AgO and nitric acid by concomitant 
oxidation of the dihydroquinone affords quinone 102. Heating of compound 102 
opens the cyclic sulfone to the diene and enables the intramolecular Diels-Alder 
reaction to close the five- and six membered rings. The next step is a transformation 
of the alcohol into a xanthate using carbon disulfide, NaH and methyl iodide. A 
followed radical reduction of the xanthate with tributyltin hydride completes the 
deoxygenation. Cleavage of the methoxy group with boron tribromide affords the 
natural product colombiasin A (22) (Scheme 20).  
 
 
Scheme 20: Total synthesis of (–)-colombiasin A (22) part 2 
 
In summary, Nicolaou used two Diels-Alder reactions to build up the main part of the 
colombiane system. The first Diels-Alder reaction generated the decaline system and 
the second closed the other two rings to the complete carbon skeleton. Intelligent 
manipulation of the functional groups and minimum use of protecting groups allowed 
him a short total synthesis in only 20 steps.49 
 
3.6 Total synthesis of (–)-elisapterosin B and (–)-colombiasin A  
by Rychnovsky et al. 2003 
 
Rychnovsky tried to synthesize a late stage precursor molecule for both natural 
products. Based on previous work of other groups, he thought it might be possible to 
synthesize elisapterosin B (18) by an intramolecular [5+2] cycloaddition and 
colombiasin A (22) per intramolecular Diels-Alder reaction of compound 103.49,50 He 
also used a Diels-Alder reaction to build up the decaline system and to introduce the 
desired stereochemistry of the side chain. The required enantiomer was prepared by 
asymmetric alkylation with pseudoephedrine as an auxiliary (Scheme 21). 
 
28 
 
Scheme 21: Retrosynthetic analysis of (–)-pseudopterosin B (18) and (–)-colombiasin A (22) 
 
The synthesis starts with an asymmetric alkylation using Myers pseudoephedrine 
auxiliary for chiral induction.51 Reduction of the amide affords aldehyde 107 with 
excellent enantioselectivity (Scheme 22). 
 
 
Scheme 22: Total synthesis of (–)-pseudopterosin B (18) and (–)-colombiasin A (22) part 1 
 
The next step is a Wittig olefination to the -unsaturated ester 108. Transformation 
in the lithium ynolate followed by treatment with LiH and acetylation with acetic 
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anhydride provides diene 105 as a single isomer.52 A Diels-Alder reaction with 
dienophile 94, prepared from commercially available 2,6-dimethoxytoluene,53 and 
diene 105 in present of lithium perchlorate generates compounds 109 and 110 in a 
1:1.7 mixture of diastereomers.54 
 
 
Scheme 23: Total synthesis of (–)-pseudopterosin B (18) and (–)-colombiasin A (22) part 2 
 
Selective reduction of the ketone next to the methoxy group with sodium borohydride 
affords an allylic alcohol. Treatment with lithium dimethylcuprate smoothly substitutes 
the acetate group. Hydrogenation followed by oxidation of the alcohol with DMP 
delivers enedione 111 (Scheme 23). Enolization with DBU and oxidation with air 
gives the corresponding quinone. Reduction of the quinone with zinc and acetylation 
with acetic anhydride delivers the hydroquinone diacetate. Cleavage of the TIPS 
group with hydrofluoric acid and subsequent oxidation with Dess-Martin periodinane 
generates aldehyde 112. A Wittig olefination produces diene 113 in a 3:1 mixture of 
double bond isomers. Cleavage of the two acetate groups and oxidation with air 
provides the key precursor 103. Treatment with boron trifluoride at 0°C initiates the 
[5+2] cycloaddition and cleaves the methoxy group to the natural compound 
elisapterosin B (18). Heating of compound 103 enables the Diels-Alder cycloaddition 
and generates the colombiane carbon skeleton. Subsequent cleavage of the 
methoxy group provides the natural product colombiasin A (22). 
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In summary, the enantioselective synthesis of (–)-elisapterosin B (18) has been 
reported with an overall yield of approx. 3% in 19 steps starting from compound 106. 
The enantioselective synthesis of (–)-colombiasin A (22) has been reported with an 
overall yield of approx. 5% in 20 steps starting from compound 106.55 
 
3.7 Total synthesis of (+)-elisapterosin B by Rawal et al. 2003 
 
Rawal´s retrosynthetic strategy based of an oxidative ring closing reaction out of an 
elisabethin derivative. This ring closing reaction could also be a possible biosynthetic 
pathway to elisapterosin B. After due considerations, he synthesized an elisabethin 
derivative which underwent oxidative cyclization to the desired target molecule. The 
elisabethane carbon skeleton was generated via an intramolecular Diels-Alder 
reaction. Further coupling reactions and functional group manipulations leaded back 
to optical pure material 119 and the aromatic compound 120 (Scheme 24). 
 
 
Scheme 24: Retrosynthetic analysis of (+)-elisapterosin (114) 
 
The optical pure starting material (S)-(+)-tetrahydro-5-oxo-2-furanacyl chloride 119 is 
prepared from inexpensive L-glutamic acid.56 The first step is a zinc chloride 
mediated and palladium catalyzed Grignard reaction of the aromatic compound 120, 
prepared via bromination out of 2,5-dimethoxytoluene,57 and the optical pure material 
119 (Scheme 25).58 Acetalization with trimethyl orthoformate under acidic conditions 
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provides the dimethyl ketal. Alkylation with NHMDS and methyl iodide affords 
compound 118 in a 8:1 mixture of diastereomers. Reduction of the lactone with 
DIBAL and subsequent treatment of the crude lactol intermediate with the Seyferth 
reagent delivers the terminal alkyne 121.59 Mesylation of the free hydroxy group and 
subsequent treatment with calcium carbonate initiates the pinacol-type 
rearrangement to methyl ester 117.60  
 
 
Scheme 25: Total synthesis of (+)-elisapterosin B (114) 
 
Treatment of 117 with NBS and catalytic amounts of silver nitrate delivers the 
terminal bromo alkyne. Hydrogenation with in situ generated diimide, prepared from 
tosyl hydrazine and sodium acetate, provides the terminal vinyl bromide exclusively 
Z-selective. A palladium catalyzed coupling reaction with E-1-bromopropene, t-BuLi 
and zinc chloride affords diene 122.61 Reduction of the ester moiety with DIBAL to 
the aldehyde followed by Wittig olefination generates the isobutenyl side chain. 
Regioselective demethylation of the more hindered methoxy group with sodium 
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ethanethionate affords phenol 123.62 Salcomine-catalyzed oxidation with oxygen 
delivers the quinone 116.63 The next step is an intramolecular Diels-Alder reaction 
followed by Wilkinson catalyzed hydrogenation of the double bond to 3-epi-
elisabethin 115. Cleavage of the methoxy group with lithium iodide and 2,6-lutidine 
followed by oxidative cyclization with CAN afford (+)-elisapterosin B (114). 
In summary, the enantioselective synthesis of (+)-elisapterosin B (114) has been 
reported with an overall yield of approx. 1% in 18 steps starting from compound 120. 
Rawal could also demonstrate that it is possible to synthesize elisapterosin B out of 
an elisabethin derivate. Furthermore, he reported that he was not able to epimerize 
3-epi-elisabethin 115 to gain elisabethin A.18 
 
3.8. Partial synthesis of elisabethin A by Mulzer et al. 2003 
 
Mulzer´s retrosynthetic strategy was based on an intramolecular Diels-Alder reaction. 
This powerful key step allowed him to close two rings and introduce four out of six 
stereogenic centers in one step. Further he decided to divide the molecule in two 
parts to achieve a highly convergent synthesis (Scheme 26). 
 
 
Scheme 26: Retrosynthetic analysis of elisabethin A (14) 
 
Hence, two different fragments were synthesized. On the one side the aromatic 
compound 129 for the quinone system and on the other the optically pure compound 
127 to prepare the diene side chain. 
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Scheme 27: Synthesis of elisabethin A (14) part 1 
 
The synthesis starts with commercially available aldehyde 129 which is converted 
into a phenol by Baeyer-Villiger oxidation and subsequent saponification of the formic 
acid ester. Selective oxidation to the para-quinone followed by reduction with sodium 
hydrosulfite delivers the hydroquinone 128. Protection of the hydroxy groups with 
TBS-Cl and regioselective bromination with NBS affords compound 130. A palladium 
catalyzed Negishi-Reformatsky reaction with ethyl tributyltin acetate and zinc 
bromide delivers ethyl ester 131.64 Reduction of the ester moiety with DIBAL provides 
the primary alcohol. Oxidation of the alcohol under Swern conditions to the aldehyde 
and a further Pinnick oxidation afford the carboxylic acid 132. Treatment with pivaloyl 
chloride generates a mixed acid anhydride which is subsequent attacked by the 
lithium auxiliary to imide 125 (Scheme 27). 
Preparation of the diene side chain starts with an olefination reaction between 
aldehyde 12765 and the phosphor component 133. Reduction of the Weinreb amide 
with DIBAL affords the-unsaturated aldehyde 135. Wittig olefination of the 
aldehyde generates the cis double bond. Cleavage of the trityl group with boron 
trichloride and subsequent substitution under Appel conditions provides the desired 
diene fragment 126 (Scheme 28).  
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Scheme 28: Synthesis of elisabethin A (14) part 2 
 
Assembling of the two fragments via an alkylation reaction delivers compound 137 
(Scheme 29). Reductive cleavage of the auxiliary with lithium borohydride followed 
by oxidation under Swern conditions generates aldehyde 138. 
 
 
Scheme 29: Synthesis of elisabethin (14) part 3 
 
A further Wittig olefination generates the isobutenyl side chain. Cleavage of the TBS 
groups with tetrabutylammonium fluoride and subsequent oxidation of the 
hydroquinone to the quinone with iron trichloride initiates the intramolecular Diels-
Alder reaction to compound 140. Unfortunately, the stereochemistry of this tricycle at 
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position 2,3,6 and 7 is not absolutely clear.66 Next steps are hydrogenation of the 
double bond, epimerization at position 7 with sodium hydroxide and cleavage of the 
methoxy group with boron tribromide to postulated final compound 141.  
In summary, the synthesis of postulated compound 141 has been reported with an 
overall yield of approx. 7% in 21 steps along the longest linear sequence.67 A 
problem of this approach is the unknown transition state and the product of the 
intramolecular Diels-Alder reaction, respectively. Furthermore, the epimerization at 
position 7 should also be impossible.18 In consideration of these facts, a totally 
different approach for the total synthesis of elisabethin is required. 
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4. Results and Discussion 
 
4.1. Retrosynthetic Analysis 
 
 
Scheme 30: Retrosynthetic analysis of elisabethin A (14) 
 
Our retrosynthetic strategy based on an early regioselective Diels-Alder reaction to 
generate the decaline system and the quaternary carbon atom at position 2. 
Furthermore, this reaction provides four stereogenic centers which are required later 
in the synthesis. Moreover, this step could be catalyzed by a chiral ligand or auxiliary 
at the aromatic compound to establish an enantioselective total synthesis. Functional 
group manipulation of the ester moiety enables the homoallylic side chain 
introduction. A subsequent ring closing reaction generates the 5 membered ring to 
complete the elisabethin core with the correct stereochemistry. Functionalization of 
the enedione system with a methyl- and a methoxy group delivers intermediate 150. 
Two different Wittig olefination reactions generate the isobutenyl side chain. A 
following cleavage of the methoxy group provides the natural product elisabethin A 
(14) (Scheme 30). 
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4.2. Preliminary Studies towards elisabethin A 
 
First target of our preliminary studies was literature known compound 160.68 The 
synthesis started with commercially available 2,5-dihydroxybenzoic acid (156). 
Esterification with sulfuric acid in methanol under reflux conditions afforded methyl 
ester 154. Diene 155 was prepared from commercially available E-2-pentenal 
(Scheme 31). Enolization with triethylamine and protection of the enol with TBSOTf 
delivered a mixture of double bond isomers which contains 25-30% of the E,E-isomer 
155. Next step was a Diels-Alder reaction with in situ oxidized hydroquinone 154 and 
diene 155 to bicycle 159. Epimerization at position 7 with aluminum oxide provided 
the desired enedione 160. 
 
 
Scheme 31: Preliminary studies, preparation of enedione 160 
 
Our next ambition was to install the homoallylic side chain at position 13. Installation 
of the homoallylic side chain via direct allylation with allylmagnesium bromide was 
unsuccessful. Just the expected allylation at the ketone moiety to compounds 161 
and 162 in a 1:1 mixture were obtained (Scheme 32). Noteworthy is the instant 
generation of the five membered lactone ring in compound 161.  
At that point it was clear that the ketone moieties have to be converted into other 
functional groups. The first attempt was to generate ketal moieties with methanol or 
ethylene glycol under reflux and different acidic conditions. Unfortunately, the 
ketones did not react at all. Experiments under more harsh conditions just resulted in 
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decomposition of the starting material. A second attempt was the reduction of the two 
ketones to the corresponding alcohols.  
 
 
Scheme 32: Direct allylation of enedione 160 
 
Therefore different reducing agents were tested (see Scheme 33 and Tab. 1). 
Reduction of enedione 160 with sodium borohydride in methanol delivered diol 164. 
This reaction condition also afforded small amounts of the lactone 165 (Entry 1). 
Reduction under Luche conditions also reduced the double bond and provided diol 
164 as main product (Entry 2). Reduction with DIBAL in methylene chloride afforded 
the desired allylic diol 163 in moderate yield (Entry 3). It is noteworthy that the ester 
moiety was stable under these conditions. A Meerwein-Ponndorf-Verley reduction of 
enedione 160 with aluminum triisopropoxide in isopropanol generated compound 166 
with inverse stereochemistry at the alcohol position (Entry 4). 
 
 
Scheme 33: Reduction of enedione 160 
 
Tab. 1: Reduction of enedione 160 
Entry Reagents Solvent Temp. Yield 
1 NaBH
4
 MeOH 0 °C 73% (164) + (165) 
2 NaBH
4, CeCl37H2O MeOH 0 °C 78% (164) + s. p. 
3 DIBAL DCM -78 °C 45% (163) 
4 Al(OiPr)
3
 iPrOH 70 °C 52% (166) 
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Next problem was to find an accurate protection group for the two alcohols in allylic 
diol 163. Protection of the allylic diol 163 with MOMCl was not successful. Only an 
inseparable mixture of mono- and diprotected product was obtained. Using more 
equivalents of MOMCl did not improve the yield. These results indicated that it is 
quite complicate to protect the diol 163. Especially the alcohol at the isopentenyl 
position was very hard to protect, probably because of sterically hindrance at this 
position. On the other side, lactonization to a five membered lactone under basic 
conditions occurred very easily. Selective reduction of the lactone 167 with DIBAL 
provided lactol 168 as a 1:1 mixture of diastereomers. Attempts to open the lactol 
with an excess of allylmagnesium bromide at room temperature or even under reflux 
conditions in THF gave no reaction. Opening with 1,3-propandithiol and boron 
trifluoride to the corresponding thioacetal resulted in decomposition (Scheme 34). 
 
 
Scheme 34: Attempt to lactol opening of compound 168 
 
4.2.1. Conclusion of the Preliminary Studies 
 
The synthesis of the literature known enedione 160 worked fine. A direct allylation at 
the ester moiety was not possible. Also the conversion of the ketone moieties into the 
corresponding ketals was unsuccessful. Reduction of the ketones was possible but 
the protection of the resulting alcohols was difficult. Furthermore, the synthesis of 
lactol 168 worked in good yields, but opening of this lactol under different conditions 
was not possible. 
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4.3. Advanced Studies towards elisabethin A 
 
At that point, two major problems occurred. The first problem was how to install the 
homoallylic side chain at position 13. The second problem was how to get the correct 
regioselectivity in the methylation- and hydroxylation reaction at the enedione system 
later in the synthesis. Fortunately, the solution for the regioselectivity problem by the 
methylation- and hydroxylation reaction simultaneously solved the allylation problem 
at position 13. The answer was to install more substituents at the aromatic precursor 
for the Diels-Alder reaction. 
 
 
Scheme 35: Synthesis of the aromatic compound 175 
 
The synthesis started by esterification of inexpensive 3-methylsalicylic acid 171 
under acidic conditions in methanol (Scheme 35). The next reaction was a Fries 
rearrangement with acetic anhydride and aluminum trichloride to methyl ketone 173. 
A subsequent Baeyer-Villiger oxidation using mCPBA as oxidant delivered 
intermediate 174. Cleavage of the acetate group with dibutyltin oxide in methanol 
under reflux conditions provided the desired Diels-Alder precursor 175. Next step 
was a Diels-Alder reaction with in situ oxidized hydroquinone 175, using Ag2O as 
oxidant, and diene 155 to bicycle 176. Epimerization at position 7 with aluminum 
oxide in toluene provided the desired trans decaline system 177 (Scheme 36). 
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Scheme 36: Synthesis of enedione 177 
 
Experiments to generate ketals of enedione 177 with methanol or ethylene glycol 
under different acidic conditions and reflux conditions were unsuccessful, similar to 
enedione 160. An explanation for the missing acetalization could be the stable 
enedione system. Therefore reduction of the double bond with zinc in acetic acid 
delivered diketone 178 as an inseparable 1:1 mixture of diastereoisomers. The 
mixture was treated with ethylene glycol and catalytic amounts of para-
toluenesulfonic acid to get the desired ketal 179. However, the starting material was 
not affected (Scheme 37). After this attempt we decided to dismiss the ketal strategy 
to focus on the reduction reaction. 
 
 
Scheme 37: Attempt to generate a ketal moiety 
 
Therefore the two ketone moieties of enedione 177 were reduced under different 
conditions (see Scheme 38 and Tab. 2). Reduction of enedione 177 with sodium 
borohydride in methanol (Entry 1) delivered alcohol 182 and diol 183 in a 1:1.2 
mixture. Noteworthy is that the methyl group of compound 182 is trans to the alcohol 
at position 8, whereas the methyl group of diol 183 is cis to the alcohol. Reduction 
under Luche conditions afforded alcohols 181 and 184 in a 1:1 mixture of 
diastereoisomers (Entry 2). It is noteworthy that only the less hindered ketone at 
position 8 is reduced. Reduction with DIBAL in methylene chloride provided the 
desired allylic diol 180 in moderate yield (Entry 3). A Meerwein-Ponndorf-Verley 
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reduction of enedione 177 with aluminum triisopropoxide in isopropanol generated 
compound 184 (Entry 4). 
 
 
Scheme 38: Reduction of enedione 177 
 
Tab. 2: Reduction of enedione 177 
Entry Reagents Solvent Temp. Yield 
1 NaBH
4
 MeOH 0 °C 55% (182) + (183) 
2 NaBH
4, CeCl37H2O MeOH 0 °C 93% (181) + (184) 
3 DIBAL DCM -78 °C 51% (180) 
4 Al(OiPr)
3
 iPrOH 70 °C 41% (184) 
 
Based on these results a second attempt was made to alkylate the lactol 186 
(Scheme 39). Hence, the next step in the synthesis was a lactonization reaction with 
sodium hydride in THF to give a five membered lactone. A following selective 
reduction of the lactone 185 with DIBAL delivered lactol 186 as a 1:1 mixture of 
diastereomers. Opening of the lactol with an excess of allylmagnesium bromide at 
room temperature or even under reflux conditions in THF was again unsuccessful, 
only unaffected starting material was recovered. The attempt to open the lactol with 
1,3-propandithiol and titanium tetrachloride as Lewis acid in methylene chloride to the 
corresponding thioacetal resulted in decomposition of the starting material. 
Thereby we reached another dead end in the synthesis. At that point we decided to 
create a new synthesis out of enedione 177. Due to the unrequested reduction of the 
enedione double bond we determined to replace this functionality. Based on results 
from enedione systems, we decided to epoxidize the double bond. 69,70 This epoxide 
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should be opened regioselectively to the desired 1,2-diketone system of elisabethin A 
(14) later in the synthesis. 
 
 
Scheme 39: Attempt to lactol opening of compound 186 
 
Compound 177 was treated with hydrogen peroxide and a catalytic amount of 
sodium hydroxide in methanol to provide epoxide 189 as single product. Reduction 
with sodium borohydride in methanol afforded diol 190 in excellent yield. 
 
 
Scheme 40: Reduction of lactone 191 
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Worth mentioning is that reduction of epoxide 189 with DIBAL delivered only 
undesired product mixtures. A subsequent lactonization with sodium hydride in THF 
provided lactone 191. Reduction of lactone 191 with DIBAL generated an alcoholate 
which attacked the epoxide and closed a new fife membered ring to the undesired full 
acetylated tetracycle 192 as single product (Scheme 40). Due to the undesired 
epoxide opening and simultaneous generation of a full acetal we decided to dismiss 
this approach. 
 
 
Scheme 41: Synthesis of aldehyde compound 196 
 
Parallel to this effort epoxide 189 was reduced under Luche conditions and revealed 
a regio- and stereoselective reduction of the ketone at position 8 to alcohol 193 in 
excellent yields. It is noteworthy that lactonization of alcohol 193 to the corresponding 
five membered lactone with sodium hydride was not possible even under reflux 
conditions. According to previous synthetic efforts, protection of the hydroxy function 
at position 8 with MOMCl and diisopropylethylamine in methylene chloride worked 
fine. Reduction of the ester moiety with DIABL afforded the primary alcohol 195. 
Several attempts to get directly the aldehyde by changing the solvents, equivalents of 
DIBAL or the reaction temperature failed. Subsequent oxidation of the primary 
alcohol with IBX generated aldehyde 196. The next goal was the installation of the 
homoallylic side chain to the aldehyde moiety. Therefore several allylation reactions 
were tested (see Scheme 42 and Tab. 3). Allylation of aldehyde 196 with 
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allylmagnesium bromide provided undesired bicycle 197 as major product (Entry 1). 
Treatment with in situ generated allylzinc chloride from allylmagnesium chloride and 
zinc chloride in diethyl ether delivered a mixture of bicycle 197 and allylic alcohol 
198, whereas 198 is a single diastereoisomer (Entry 2). A Sakurai allylation with allyl-
TMS and tin tetrachloride at -78 °C gave no reaction (Entry 3). Another Sakurai 
allylation by the use of the same reagents at -10°C leaded to decomposition of the 
starting material (Entry 4). Allylation under Brown conditions did not affect the starting 
material (Entry 5). Treatment of aldehyde 196 with allyl tributyltin and magnesium 
bromide as Lewis acid at room temperature afforded allylic alcohol 198 as single 
product (Entry 6). Worth mentioning is that the TBS protection group underwent a 
1,5-migration to the generated alcohol at the side chain.  
 
 
Scheme 42: Allylation of aldehyde 196 
 
Tab. 3: Allylation of aldehyde 196 
Entry Reagents Solvent Temp. Yield 
1 Allyl-MgBr THF -10 °C 46% (197) + side prod. 
2 Allyl-ZnCl THF -78 °C 73% (197) +24% (198) 
3 Allyl-TMS, SnCl
4
 DCM -78 °C no reaction 
4 Allyl-TMS, SnCl
4
 DCM -10 °C decomposition 
5 Allyl-B(IPC)
2
 Et
2
O -100 °C no reaction 
6 Allyl-Sn(Bu)
3
, MgBr
2
 DCM r.t. 40% (198) 
7 Allyl-Sn(Bu)
3
, BF
3
OEt
2
 DCM -78 °C → 0 °C 48% (198) 
8 Allyl-Br, CrCl
2
 DMF r.t. 80% (199) 
 
Allylation with allyl tributyltin and boron trifluoride as Lewis acid also provided allylic 
alcohol 198 with slightly better yields (Entry 7). It is noteworthy that this reaction only 
worked with 0.5-0.6 equivalents of boron trifluoride with respect to the starting 
material. One or more equivalents of boron trifluoride leaded to decomposition of the 
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starting material. A NHK coupling by the use of chromium dichloride and allylbromide 
in DMF only eliminated the epoxide to ,-unsaturated ketone 199 (Entry 8). 
In summary, all of the allylation reactions were not really satisfying due to their 
moderate yields. Hence, further experiments were made to improve the yield. An 
attempt to improve the yield was to inhibit the elimination reaction. Therefore we 
decided to eliminate the double bond to get a more flexible six membered ring 
system and to avoid a 1,5-conjugated dienone system in the undesired product 197. 
Based on this consideration, aldehyde 196 was hydrogenated with molecular 
hydrogen and palladium on charcoal in ethyl acetate to saturated bicycle 200, but 
subsequent allylation of the aldehyde by in situ generated allylzinc chloride delivered 
compounds 201 and 202 as main products with unknown stereochemistry in poor 
yields (Scheme 43). Although the configuration at the newly formed center could not 
have been assigned, only one diastereomer was formed. 
 
 
Scheme 43: Allylation of saturated bicycle 200 
 
Due to this result we knew that the double bond was not the driving force for the 
elimination reaction. In another experiment we treated the primary alcohol 195 with 
sodium hydride in THF and observed the same product as the elimination product 
197 in the allylation reaction. Based on this result it was clear that a Grob 
fragmentation occurred (Scheme 44).  
 
 
Scheme 44: Fragmentation of primary alcohol 195 
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A closer look on the reaction mechanism revealed the perfect antiperiplanar 
configuration of the alcoholate intermediate on the side chain to the leaving group in 
our case the OTBS group. A further preferential of this fragmentation was may be the 
rigid decaline system and the 1,3-dicarbonyl arrangement (Scheme 45).  
 
 
Scheme 45: Grob fragmentation mechanism 
 
This reaction mechanism also explains the 1,5-migration of the protection group. The 
alcoholate intermediate interacts with the TBS group via a six membered transition 
state and enables a 1,5-migration (Scheme 46). The alcoholate was consequently 
trapped and inhibits the fragmentation reaction. This migration only occurred if the 
new generated chiral center at position 13 was in (R)-configuration. The (S)-
configuration had maybe to strong interactions between the homoallylic side chain 
and the MOM group. Thus, a six membered transition state was not possible and 
fragmentation to product 195 occurred. This assumption would also explain the 
stereoselective product 198 and the maximum yield of 48%. 
 
 
Scheme 46: Migration of the protection group 
 
With these results in hand our next goal was to generate the five membered ring. 
One approach based on a reductive radical ring closing reaction (Scheme 47). The 
double bond in the six membered ring should stabilize the radical intermediate. 
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Moreover, this reaction required a functional group which is able to generate a radical 
at position 3. Functionalization of the hydroxy group into a xanthate with phenyl 
chlorothionoformate was unsuccessful. Substitution into an allyl bromide with thionyl 
bromide or hydrogen bromide was not possible. Only unaffected starting material 
was recovered.  
 
 
Scheme 47: Reductive radical ring closing 
 
At that point we decided to try a palladium catalyzed ring closing reaction. Therefore 
the hydroxy group at position 3 was transformed into an acetate using acetic 
anhydride, DMAP and triethylamine. Unfortunately, the following palladium catalyzed 
ring closing reaction was unsuccessful. The starting material 212 was not affected 
under these conditions. The TBS group was probably to bulky and pushed the side 
chain away from the reactive transition state so that the reaction could not proceed 
(Scheme 48). 
 
 
Scheme 48: Attempt to palladium catalyzed ring closing with allylic acetate 212 
 
Due to this consideration the TBS group and the MOM group of allylic alcohol 198 
were cleaved with sulfuric acid in methanol to triol 214. Subsequent protection of all 
alcohols with acetic anhydride, DMAP and triethylamine delivered triacetate 215. The 
following palladium catalyzed ring closing reaction provided compounds 216 and 217 
in an inseparable 1:1 mixture of double bond isomers. Unfortunately these conditions 
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also opened the epoxide and generated an additional five membered heterocycle. A 
subsequent acetylation of the hydroxy group at position 9 delivered the second 
acetate group. Hydrogenation of the product mixture with molecular hydrogen and 
palladium on charcoal provided tetracycle 218 as single product (Scheme 49). 
 
 
Scheme 49: Preparation of compound 218 
 
This preparation sequence revealed that the palladium catalyzed ring closing 
reaction worked. Also the hydrogenation of the double bonds delivered the product 
with the desired stereochemistry. The only problem was the opening of the epoxide 
during the ring closing reaction. According to these facts we decided to open the 
epoxide earlier in the synthesis. Therefore we attempted to open the epoxide of 
compound 189 to the desired hydroxy enedione 219 (see Scheme 50 and Tab. 4). 
Treatment of epoxide 189 with sulfuric acid in acetic acid delivered only the 
undesired allylic acetate 221 (Entry 1). These conditions only cleaved the TBS group 
to the alcohol. A subsequently esterification with acetic acid generated the acetate 
moiety. Epoxide opening with boron trifluoride cleaved the TBS group and afforded 
alcohol 222 (Entry 2). Hence, acidic conditions did not affect the epoxide moiety. 
Treatment with 30 wt.% sodium hydroxide in methanol decomposed the starting 
material (Entry 3). Treatment with LDA in THF led to decomposition too (Entry 4). 
Epoxide opening with sodium methanolate in methanol gave no reaction (Entry 5). 
Due to these results even under basic conditions it was not possible to open the 
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epoxide. After these attempts we tried some reductive epoxide opening conditions to 
synthesize alcohol 220. Treatment with an excess of hydrazine in ethanol did not 
affect the starting material (Entry 6).71 Treatment with titanocene dichloride and zinc 
was unsuccessful too (Entry 7).72 Epoxide opening under radical conditions by the 
use of tributyltin hydride and AIBN gave no reaction (Entry 8).73 
 
 
Scheme 50: Attempts to open the epoxide 
 
Tab. 4: Attempts to open the epoxide 
Entry Reagents Solvent Temp. Yield 
1 H2SO4 AcOH r.t. 93% (221) 
2 BF
3
OEt
2
 Et
2
O 0 °C 73% (222) 
3 30 wt.% NaOH MeOH r.t. decomposition 
4 LDA THF -78 °C → r.t. decomposition 
5 NaOMe MeOH 50°C no reaction 
6 H2NNH2 EtOH 0 °C → r.t. no reaction 
7 Cp2TiCl2, Zn DCM -78 °C no reaction 
8 nBu3SnH, AIBN Toluene 100 °C no reaction 
 
Parallel to these efforts we attempted to install the isobutenyl side chain before we 
close the five membered ring. Based on this consideration we decided to generate 
the homoallylic side chain from an ,-unsaturated ester and install the isobutenyl 
side chain via conjugate addition (Scheme 51). 
 
 
Scheme 51: Attempts for isobutenyl side chain installation 
51 
First we had to generate the ,-unsaturated ester via an olefination reaction. 
Therefore, several olefination reagents were tested (see Scheme 52 and Tab. 5). 
Olefination with the corresponding Wittig reagent in methanol at room temperature 
was unsuccessful (Entry 1). Heating of the reaction mixture afforded well known 
bicycle 197 and the deformylated bicycle 224 (Entry 2). A further reaction with the 
same Wittig reagent at 60 °C in toluene gave no reaction (Entry 3). These results 
indicated that the aldehyde moiety in the previous experiment reacted with the 
methanol instead of the Wittig reagent. Changing the Wittig reagent to a MOM-Wittig 
also did not affect the starting material (Entry 4). Olefination with the corresponding 
Horner reagent at room temperature or even at 0 °C also provided compounds 197 
and 224 (Entry 5 and 6). 
 
 
Scheme 52: Olefination of aldehyde 196 
 
Tab. 5: Attempts to olefinate aldehyde 196 
Entry Reagents Solvent Temp. Yield 
1 MeO2CCHPPh3 MeOH r.t. no reaction 
2 MeO2CCHPPh3 MeOH 60 °C 70% (197) + 20% (224) 
3 MeO2CCHPPh3 Toluene 60 °C no reaction 
4 MeOCH2PPh3, tBuOK THF r.t. no reaction 
5 EtO2CCH2PO(OEt)2, NaH THF r.t. 77% (197) + 20% (224) 
6 EtO2CCH2PO(OEt)2, NaH THF 0 °C 77% (197) + 19% (224) 
 
4.3.1. Conclusion of the Advanced Studies 
 
Preparation of a more complex aromatic precursor for the Diels-Alder reaction was 
successful. Furthermore, it was possible to generate the aldehyde functionality at 
position 13. Also, the allylation reaction at the aldehyde to install the homoallylic side 
chain worked under moderate yields. Attempts to improve the yield of this reaction 
failed. Subsequent experiments revealed that a radical ring closing reaction was not 
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possible due to the inaccessibility of the neopentylic position. Moreover it was shown 
that a palladium catalyzed ring closing reaction followed by hydrogenation of the 
double bonds delivers the desired five membered carbon ring and simultaneously an 
additional undesired heterocycle. Following attempts to avoid this side reaction by 
opening the epoxide in an earlier stage of the synthesis were unsuccessful. Also, the 
synthesis of an ,-unsaturated ester from aldehyde 196 delivered no satisfying 
results. 
 
4.4. New Approach to elisabethin A 
 
At that point we had two unanswered questions. The question was how to open the 
epoxide and the second how to install the side chains. After careful considerations 
we decided to attempt a new retrosynthetic strategy. This strategy based on a late 
stage palladium catalyzed ring closing. A further modification was the higher 
substituted aromatic compound which contained all of the required functional groups. 
The strategy to generate the decaline system via a Diels-Alder reaction was the 
same as in the first retrosynthesis.  
 
 
Scheme 53: New retrosynthetic strategy to elisabethin A (14) 
 
The first target of the new synthesis was ,-unsaturated ester 227. The synthesis 
started with commercially available 1,2,4-trimethoxybenzene 228 (Scheme 54). 
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Ortho-metalation with nBuLi and subsequent treatment with methyl iodide delivered 
2,3,6-trimethoxytoluene 229.74 Regioselective oxidative demethylation of the two 
para methoxy groups with PIDA provided the quinone. Reduction of the quinone with 
sodium hydrosulfite afforded the hydroquinone 230. Protection of the two hydroxy 
groups with MOMCl and sodium hydride delivered compound 231. A regioselective 
electrophilic aromatic substitution with NBS generated arylbromide 233. The next 
step was a transmetalation reaction with t-BuLi followed by treatment with DMF to the 
desired aldehyde. An E-selective olefination reaction with the corresponding Horner 
reagent delivered the ,-unsaturated methyl ester. Cleavage of the MOM group with 
hydrochloric acid in methanol provided the Diels-Alder precursor 227. 
 
 
Scheme 54: Synthesis of aromatic compound 227 
 
The next step was a Diels-Alder reaction with in situ oxidized hydroquinone 154 and 
diene 229 generated the desired bicycle 235 as single product (Scheme 55). 
 
 
Scheme 55: Attempt for isobutenyl side chain introduction 
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Diene 209 was prepared from commercially available E-2-pentenal. Enolization with 
triethylamine and protection of the enol with TBSOTf delivered a mixture of double 
bond isomers which contains 25-30% of the E,E-isomer. Subsequent conjugate 
addition of the cuprate reagent to the ,-unsaturated methyl ester was 
unsuccessful. Only unaffected starting material was recovered. The conjugate 
addition was maybe too hindered because of the MOM group ortho to the side chain. 
At that point we decided to install the isobutenyl side chain directly on the aromatic 
compound. Due to this consideration we transformed the ester moiety into the tertiary 
alcohol 238 by the use of methylmagnesium bromide. The resulting alcohol was 
esterificated with acetic anhydride, triethylamine and DMAP in methylene chloride to 
allylic acetate 239 (Scheme 56). 
 
 
Scheme 56: Modification of compound 239 
 
A planned Ireland-Claisen rearrangement from allylic acetate 239 to the desired acid 
240 was unsuccessful. Only unaffected starting material was recovered. Heating of 
the reaction mixture led to decomposition. The next attempt was a Tsuji-Trost allylic 
alkylation with dimethylmalonate to the desired -alkylated compound, but 
unfortunately the nucleophilic attack occurred in -position at the two methyl groups 
to dimethyl ester 241. (Scheme 57) 
 
 
Scheme 57: Attempts from allylic acetate 239 
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An Eschenmoser-Claisen rearrangement with N,N-dimethylacetamide-dimethylacetal 
and allylic alcohol 238 in hot xylene was also unsuccessful. The starting material was 
not affected under these conditions. The conjugated position of the double bond to 
the aromatic ring could be an explanation for the failed rearrangement. Obviously the 
starting material was the more stable compound in the equilibrium. 
 
5. Conclusion and Outlook 
 
Many complex diterpenes isolated from Pseudopterogorgia Elisabethae were 
synthesized in the last ten to fifteen years from different synthetic research groups. 
After all, elisabethin A is one of the few natural compounds which has not been 
synthesized until now. Many different approaches from several workgroups were 
tested but none of them were successful. This master thesis dealt with the total 
synthesis of elisabethin A too, but unfortunately the total synthesis could not be 
finished in the course of this master thesis. However, we reported a totally different 
route to synthesize this natural component. In contrast to other reported approaches 
we generated first the decaline system including the quaternary carbon atom via a 
highly regioselective Diels-Alder reaction. After several functional group 
manipulations at the enedione system we installed the homoallylic side via a tin 
mediated allylation. At that point we discovered the high tendency for a Grob 
fragmentation of this system. After several failed attempts to inhibit this fragmentation 
we decided to manage the ring closing reaction. Here we found that a palladium 
catalyzed ring closing reaction is the reaction of choice. Furthermore, we finished the 
elisabethin core with the correct stereochemistry via simple hydrogenation of the 
double bonds. Following attempts to open the epoxide which should avoid the 
generation of a five membered heterocycle during the carbon ring closing reaction 
were unsuccessful. Based on these results we decided to substitute the acetate 
group at the homoallylic side chain by an isobutenyl moiety. Installation of the side 
chain via conjugate addition to an ,-unsaturated methyl ester was not possible. 
Hence, we attempted to install the isobutenyl side chain earlier in the synthesis at the 
aromatic compound, but it was not possible to generate the desired -branched 
aromatic compound via [3,3]-sigmatropic rearrangements or a Tsuji-Trost allylation. 
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According to these last results we want to give a short outlook to a possible synthetic 
pathway (Scheme 58). 
The synthesis starts from inexpensive commercially available iso-vanilline (242). 
Oxidation of the starting material with peracetic acid and subsequent saponification 
with potassium hydroxide delivers diol 243.75  
 
 
Scheme 58: Possible synthetic way to elisabethin A (14) 
 
Treatment of diol 243 with ethyl 3,3-diethoxypropionate in phosphoric acid affords 
literature known scopoletin (244).76 The next step is a protection of the hydroxy group 
with MOMCl and DIPEA. A following asymmetric conjugate addition (ACA) to the ,-
unsaturated lactone with isobutenylmagnesium bromide, cupper bromide and a chiral 
ligand provides compound 245.77 
Regioselective ortho-metalation with nBuLi using the MOM group as directing moiety 
and subsequent treatment with methyl iodide delivers bicycle 246.78 Reduction of the 
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lactone with DIBAL provides the lactol. Opening of the lactol via a Wittig olefination 
generates the terminal double bond in phenol 247.79 The next step is a Diels-Alder 
reaction by in situ oxidative demethylation of phenol 247, using cerammonium nitrate 
as oxidant and diene 248 to afford bicycle 249.80 The diene 248 is prepared from 
commercially available E-2-pentenal. Enolization with potassium acetate and 
protection of the enol with acetic anhydride delivered a mixture of double bond 
isomers which contains 25-30% of the E,E-isomer.81 Epimerization using DBU as 
base delivers the trans-annulated decaline system. A palladium catalyzed ring 
closing reaction followed by hydrogenation of the generated double bonds with 
molecular hydrogen delivers the correct elisabethane skeleton. Cleavage of the MOM 
group under acidic conditions provides elisabethin A (14). 
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6. Experimental Part 
 
6.1. General Information 
 
All moisture and oxygen sensitive reactions were performed in flame-dried glassware 
under a slight argon overpressure. All reactions were stirred magnetically. Sensitive 
solutions, solvents or reagents were transferred via cannula or syringe. Reactions 
were monitored by thin-layer chromatography (TLC) or NMR of the crude mixture. 
Evaporations were conducted under reduced pressure at temperatures less than 
40°C, unless otherwise noted. Further dryings of the residues were accomplished 
using a high vacuum pump. 
 
All solvents (except dichloromethane and methanol) were purchased as the highest 
available grade from Sigma-Aldrich, Acros-Organics or Fisher-Chemicals. Anhydrous 
dichloromethane was purified by filtration through alumina under argon immediately 
before use. Methanol was heated under reflux for several hours over sodium before 
being distillated. NEt3, iPr2NEt, and iPrNH were distilled over CaH2 before use. Ethyl 
acetate and hexane for column chromatography were distilled and used without 
further purification. All other reagents were used as received from Sigma-Aldrich, 
Acros-Organics, TCI or Fisher-Chemicals unless otherwise noted. 
 
Thin-layer chromatographies (TLC) were carried out on pre-coated Merk silica gel 60 
F254 to monitor all reactions. The detection was first performed using UV (254 nm) 
as a visualizing agent followed by immersion in an aqueous solution of 
phosphomolybdic acid (20 g), ceric(IV)sulfate (0.4 g) and 22 mL of sulfuric acid. 
Treatment with a heat-gun eventually revealed the state of the reaction. Preparative 
column chromatography was performed with silica gel 60 from Merk (0.040-
0.063 µm, 240-400 mesh). The columns were packed with a suspension of gel in 
hexane and eluted with an appropriate solvent combination using a hand-pump 
overpressure. 
 
All NMR spectra were measured on a Bruker AV400 or DRX400. Chemical shifts are 
given in ppm and referenced to the solvent residual peaks (CDCl3 
1H, = 7.26 ppm, 
13C, = 77.00 ppm). Data are reported as follows: chemical shift, multiplicity (s = 
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singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constant J, 
integration. 
 
Infrared spectra were recorded as thin films of pure products on an ATR-unit on a 
Bruker Vertex 70. High-resolution mass spectra were measured on Bruker MaXis 
(ESI-TOF) with a resolution of 10.000. 
 
6.2. Experimental Procedures 
 
Methyl 2,5-dihydroxybenzoate 154 
 
 
 
To a solution of 2,5-Dihydroxybenzoic acid (156) (5 g, 32.45 mmol) in MeOH (40 mL) 
was added conc. H2SO4 (2 mL, 38 mmol). The reaction mixture was stirred under 
reflux for 20 hours. The solution was cooled to r.t. and treated with water. The 
organic layer was extracted with diethyl ether (3x), washed with brine and dried over 
MgSO4. The solvent was removed by rotary evaporation to the crude product 154 
(5.19 g, 95%) as a brown solid and was used in the next step without further 
purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 10.31 (s, 1H), 7.28 (d, J = 3.1 Hz, 1H), 7.0 (dd, 
J = 9.0, 3.1 Hz, 1H), 6.88 (d, J = 9.0 Hz, 1H), 3.94 (s, 3H), 2.89 (s, 1H). 
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1-(tert-Buthyldimethylsilyl)-oxypenta-1,3-dien 155 
 
 
 
To a stirred solution of trans-2-pentenal (9 mL, 92 mmol) and triethylamine (19 mL, 
140 mmol) in CH2Cl2 (150 mL) was added dropwise tert-buthyldimethylsilyl triflate 
(21.7 mL, 95 mmol) at 0°C. After the addition the mixture was heated to reflux for 6 h. 
To the resulting mixture was added aq. NaHCO3, and the organic layer was 
separated. The separated organic layer was washed with brine, dried, and 
concentrated in vacuo. Vacuum distillation (1 mbar, 45 – 52 °C) of the residue 
afforded 14.48 g of an oily mixture of stereoisomeric 1-(tert-buthyldimethylsilyl)-
oxypenta-1,3-diens (155) which contained 25 – 30% of the (E,E) isomer. 
 
DA adduct 159 
 
 
 
To a suspension of 154 (740 mg, 4.4 mmol) and 1-tert-buthyldimethylsiloxypenta-1,3-
diene (155) (2.80 g, 9.52 mmol, mixture of stereoisomers) in toluene (7.5 mL) at 10°C 
was added silver(I)oxide (2.04 g, 8.8 mmol) in one portion. The mixture was warmed 
to room temperature and stirred for 19 h, then was diluted with diethyl ether, and 
filtered through Celite. The Celite was washed thoroughly with diethyl ether, and the 
filtrate was concentrated in vacuo. The residue was purified by column 
chromatography (hexane/EtOAc, 10:1) to give 159 (1.246 g, 78%) as clear oil. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.77 (d, J = 10.2 Hz, 1H), 6.58 (d, J = 10.2 Hz, 
1H), 5.69 (m, 2H), 4.79 (m, 1H), 3.77 (s, 3H), 3.65 (d, J = 4.9 Hz, 1H) 2.18 (m, 1H), 
1.43 (d, J = 7.7 Hz, 3H), 0.75 (s, 9H), 0.02 (s, 3H), -0.07 (s, 3H). 
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Epi-DA adduct 160 
 
 
 
A mixture of 159 (1.0 g, 2.75 mmol) and neutral alumina (26 g Brockman Activity II, 
M70 – 220) in toluene (70 mL) was stirred for 4 h at room temperature. The resulting 
mixture was filtered and washed with EtOAc. Concentration of the filtrate afforded 
160 (0.96 g, 96%) as a white solid and was used in the next step without further 
purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.83 (d, J = 10.3 Hz, 1H), 6.58 (d, J = 10.3 Hz, 
1H), 5.81 (ddd, J = 9.9, 5.6, 2.0 Hz, 1H), 5.64 (dd, J = 9.9, 3.0 Hz, 1H), 5.01 (d, 
J = 5.6 Hz, 1H), 3.61 (s, 3H), 3.35 (d, J = 9.0 Hz, 1H), 2.85 (m, 1H), 1.21 (d, 
J = 6.8 Hz, 3H), 0.81 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H). 
 
Lactone 161 and diallyl 162 
 
 
 
To a solution of 160 (170 mg, 0.46 mmol) in THF (4 mL) was added allylmagnesium 
bromide (0.47 mL, 1 M solution in diethyl ether, 0.47 mmol) dropwise at -20 °C. After 
stirring at room temperature for 5 h, the resulting solution was quenched with aq. 
ammonium chloride, extracted with CH2Cl2 (3x), washed with brine and dried over 
MgSO4. The solvent was removed by rotary evaporation. The residue was purified by 
column chromatography (hexane/EtOAc, 20:1) to give 161 (43 mg, 25%) and 162 
(66 mg, 32%). 
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Lactone 161 
 
1H NMR (400 MHz, CDCl3):  (ppm) 7.28 (d, J = 9.5 Hz, 1H), 6.01 (d, J = 9.5 Hz, 1H), 
5.98 (ddd, J = 10.0, 5.9, 1.8 Hz, 1H), 5.85 (m, 1H), 5.69 (dd, J = 10.0, 4.3 Hz, 1H), 
5.35 (m, 2H), 4.85 (d, J = 6.0 Hz, 1H), 2.92 (d, J = 5.5 Hz, 1H), 2.91 (m, 1H), 2.65 (m, 
1H), 2.63 (m, 1H), 1.21 (d, J = 7.0 Hz, 3H), 0.81 (s, 9H), 0.14 (s, 3H), 0.11 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 190.4 171.5, 151.4, 134.5, 130.8, 128.9, 127.0, 
121.7, 85.3, 69.6, 61.5, 56.4, 37.4, 29.4, 26.2, 23.1, 18.3, -3.8, -4.6 ppm. 
 
HRMS: calculated for C21H30O4SiNa
+: 397.1806; found: 397.1821 
 
Diallyl 162 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.90 (m, 2H), 5.74 (m, 1H), 5.64 (dd, J = 9.5, 
4.5 Hz, 1H), 5.58 (d, J = 10.4 Hz, 1H), 5.47 (d, J = 10.4 Hz, 1H), 5.10 (m, 4H), 4.71 
(d, J = 5.8 Hz, 1H), 4.61 (s, 1H), 3.60 (s, 3H), 3.01 (m, 1H), 2.78 (m, 1H), 2.67 (d, 
J = 7.7 Hz, 3H), 2.55 (m, 3H), 2.46 (m, 1H), 1.27 (d, J = 6.9 Hz, 3H), 0.88 (s, 9H), 
0.14 (s, 3H), 0.08 (s, 3H). 
 
HRMS: calculated for C25H40O5SiNa
+: 471.2538; found: 471.2535 
 
63 
Diol 164 and lactone 165 
 
 
 
To a solution of 160 (300 mg, 0.82 mmol) in MeOH (12 mL) was added NaBH4 
(311 mg, 8.2 mmol) at 0°C. The reaction mixture was stirred for 2 h at 0 °C. The 
resulting mixture was quenched with aq. ammonium chloride, extracted with CH2Cl2 
(3x), washed with brine and dried over MgSO4. The solvent was removed by rotary 
evaporation. The residue was purified by column chromatography (hexane/EtOAc, 
3:1) to give 164 (222 mg, 73%) as a withe solid and 165 (17 mg, 6%). 
 
Diol 164 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.80 (dd, J = 9.9, 3.1 Hz, 1H), 5.70 (ddd, J = 9.9, 
5.6, 2.1 Hz, 1H), 5.43 (d, J = 2.3 Hz, 1H), 5.07 (d, J = 9.8 Hz, 1H), 4.73 (d, 
J = 5.6 Hz, 1H), 4.30 (m, 1H), 4.10 (m, 1H), 3.67 (s, 3H), 2.84 (m, 1H), 2.21 (m, 2H), 
1.71 (m, 1H), 1.60 (m, 1H), 1.51 (m, 1H), 1.10 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 0.20 
(s, 3H), 0.13 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 176.3, 141.1, 125.5, 71.9, 71.3, 64.5, 55.1, 53.3, 
37.9, 30.4, 27.7, 25.7, 24.6, 18.9, 17.9, -3.0, -4.5 ppm. 
 
HRMS: calculated for C19H34O5SiNa
+: 393.2068; found: 393.2063 
 
64 
Lactone 165 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.66 (ddd, J = 10.3, 3.7, 2.4 Hz, 1H), 5.61 (m, 
1H), 4.58 (m, 1H), 4.55 (m, 1H), 4.14 (m, 1H), 4.11 (m, 1H), 2.41 (d, J = 8.7 Hz, 1H), 
1.97 (m, 3H), 1.85 (m, 2H), 1.15 (d, J = 7.2 Hz, 3H), 0.93 (s, 9H), 0.22 (s, 3H), 0.19 
(s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 177.1, 134.7, 127.4, 81.9, 68.8, 67.6, 54.9, 43.5, 
30.3, 26.8, 25.8, 24.5, 20.1, -4.1, -4.8 ppm. 
 
HRMS: calculated for C18H30O4SiNa
+: 361.1806; found: 361.1804 
 
Diol 164 (using NaBH4 and CeCl37H2O) 
 
 
 
To a solution of 160 (100 mg, 0.27 mmol) and CeCl37 H2O (201 mg, 0.54 mmol) in 
MeOH (5 mL) was added NaBH4 (97 mg, 2.57 mmol) at 0 °C. The reaction mixture 
was stirred for 2 h at 0 °C. The resulting mixture was quenched with aq. ammonium 
chloride, extracted with CH2Cl2 (3x), washed with brine and dried over MgSO4. The 
solvent was removed by rotary evaporation. The residue was purified by column 
chromatography (hexane/EtOAc, 3:1) to give 164 (78 mg, 78%) as a withe solid.  
 
(Spectroscopic data see page 63) 
 
65 
Diallylic alcohol 163 
 
 
 
To a solution of 160 (340 mg, 0.93 mmol) in CH2Cl2 (3 mL) was added DIBAL 
(2.8 mL, 1 M in toluene, 2.8 mmol) dropwise at -78 °C under an argon atmosphere. 
The reaction mixture was stirred at -78 °C for 1 h and quenched with MeOH. After 
15 min the resulting mixture was warmed to room temperature, diluted with water and 
aq. Na,K- tartrate, extracted with diethyl ether (2x) and CH2Cl2 (1x), washed with 
brine and dried over MgSO4. The solvent was removed by rotary evaporation. The 
residue was purified by column chromatography (hexane/EtOAc, 6:1) to give 163 
(160 mg, 45%) as a clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.04 (dd, J = 10.0, 3.5 Hz, 1H); 5.92 (ddd, 
J = 10.0, 5.8, 1.8 Hz, 1H); 5.86 (dd, J = 10.0, 3.0 Hz, 1H); 5.68 (ddd, J = 9.8, 5.3, 
2.3 Hz, 1H), 5.40 (d, J = 0.8 Hz, 1H), 4.75 (d, J = 5.2 Hz, 1H), 4.55 (dd, J = 5.8, 
0.8 Hz, 1H), 4.35 (m, 1H), 3.81 (d, J = 11.8 Hz, 1H), 3.63 (s, 3H), 2.96 (m, 1H), 2.53 
(dd, J = 9.9, 7.2 Hz, 1H), 1.18 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 0.21 (s, 3H), 0.15 (s, 
3H). 
 
66 
Allylic alcohol 166 
 
 
 
To a solution of 160 (100 mg, 0.27 mmol) in iPrOH (1.1 mL) was added Al(OiPr)3 
(248 mg, 1.22 mmol). The mixture was boiled gently, and acetone and iPrOH were 
distilled slowly from the reaction mixture through a short column. From time to time 
iPrOH was added to maintain a constant volume. After 18 h the reaction mixture was 
concentrated under reduced pressure, treated with 1 M HCl, and extracted with 
CH2Cl2 (3x). The organic layer was washed with sat. NaHCO3 and brine, dried over 
MgSO4 and concentrated in vacuo. . The residue was purified by column 
chromatography (hexane/EtOAc, 6:1) to give 166 (52 mg, 52%) as a withe solid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.87 (dd, J = 10.3, 2.1 Hz, 1H), 5.95 (dd, 
J = 10.3, 2.1 Hz, 1H), 5.79 (ddd, J = 9.8, 5.5, 2.0 Hz, 1H), 5.58 (dd, J = 9.8, 2.8 Hz, 
1H), 5.30 (s, 1H), 5.15 (tt, J = 9.0, 2.0 Hz, 1H), 4.95 (d, J = 5.6 Hz, 1H), 3.60 (s, 3H), 
2.62 (m, 1H), 2.53 (t, J = 9.2 Hz, 1H), 1.71 (d, J = 8.9 Hz, 1H), 1.32 (d, J = 7.0 Hz, 
3H), 0.80 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 192.5, 168.9, 154.0, 137.9, 127.7, 126.5, 70.9, 66.3, 
64.4, 52.9, 46.3, 35.7, 26.1, 22.4, 18.3, -4.1, -5.0 ppm. 
 
IR: 3473, 3028, 2855, 1728, 1682, 1462, 1390, 1251, 1071, 840 cm-1 
 
HRMS: calculated for C19H30O5SiNa
+: 389.1755; found: 389.1762 
 
67 
Lactone 167 
 
 
 
To a solution of 163 (100 mg, 0.27 mmol) in THF (4 mL) was added NaH (27 mg, 
60% in mineral oil, 0.68 mmol) at 0 °C. After stirring at room temperature for 1 h, the 
resulting solution was quenched with aq. ammonium chloride, extracted with EtOAc 
(3x), washed with brine and dried over MgSO4. The solvent was removed by rotary 
evaporation to the crude product 167 (90 mg, 99%) as a clear liquid and was used in 
the next step without further purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.41 (dd, J = 9.3, 5.5 Hz, 1H); 5.94 (ddd, J = 9.3, 
4.0, 1.0 Hz, 1H); 5.71 (dt, J = 10.2, 2.3 Hz, 1H); 5.65 (dt, J = 10.4, 2.0 Hz, 1H), 4.84 
(d, J = 1.8 Hz, 1H), 4.81 (q, J = 2.6 Hz, 1H), 4.61 (d, J = 5.5 Hz, 1H), 4.48 (dd, 
J = 4.0, 1.3 Hz, 1H), 2.43 (d, J = 10.0 Hz, 1H), 1.91 (m, 1H), 1.19 (d, J = 7.0 Hz, 3H), 
0.96 (s, 9H), 0.28 (s, 3H), 0.23 (s, 3H). 
 
1H NMR 
 
68 
Lactol 168 
 
 
 
To a solution of 167 (100 mg, 0.27 mmol) in CH2Cl2 (1 mL) was added DIBAL 
(0.57 mL, 1 M in toluene, 0.57 mmol) dropwise at -78 °C under an argon atmosphere. 
The reaction mixture was stirred at -78 °C for 1.5 h and quenched with MeOH. After 
15 min the resulting mixture was warmed to room temperature, diluted with water and 
aq. Na,K- tartrate, extracted with diethyl ether (2x) and CH2Cl2 (1x), washed with 
brine and dried over MgSO4. The solvent was removed by rotary evaporation. The 
residue was purified by column chromatography (hexane/EtOAc, 3:1) to give 168 
(55 mg, 60%) in a 1:1 mixture of diastereomers. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.34 (dd, J = 9.3, 5.5 Hz, 1H), 6.20 (dd, J = 9.3, 
5.8 Hz, 1H), 5.94 (ddd, J = 9.3, 4.3, 1.0 Hz, 1H), 5.74 (m, 4H), 5.65 (m, 1H), 5.06 (m, 
2H), 4.82 (d, J = 7.8 Hz, 1H), 4.73 (d, J = 1.5 Hz, 1H), 4.70 (q, J = 2.4 Hz, 1H), 4.67 
(dd, J = 4.3, 1.5 Hz, 1H), 4.44 (m, 1H), 4.31 (d, J = 5.2 Hz, 1H), 4.26 (dd, J = 4.3, 
1.5 Hz, 1H), 4.17 (d, J = 5.5 Hz, 1H), 2.86 (m, 1H), 2.71 (m, 1H), 2.23 (d, J = 9.3 Hz, 
1H), 2.12 (d, J = 9.6 Hz, 1H), 2.04 (m, 2H), 1.12 (d, J = 7.0 Hz, 6H), 0.95 (s, 18H), 
0.22 (s, 3H), 0.19 (s, 9H). 
 
69 
Methyl 2-hydroxy-3-methylbenzoate 172 
 
 
 
To a solution of 3-Methylsalicylic acid 171 (10 g, 66 mmol) in MeOH (200 mL) was 
added conc. H2SO4 (7 mL, 132 mmol). The reaction mixture was stirred under reflux 
for 72 hours. The solution was cooled to r.t. and neutralized with 25% NaOH and 
NaHCO3. The organic layer was extracted with EtOAc (3x), washed with brine and 
dried over MgSO4. The solvent was removed by rotary evaporation. The crude 
product was purified by flash chromatography on silica gel eluting with a mixture of 
hexane and EtOAc (10:1) to yield the methyl ester 172 (9.23 g, 84%) as a clear 
liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 11.0 (s, 1H), 7.68 (d, J = 8.2 Hz, 1H), 7.31 (d, 
J = 7.3 Hz, 1H), 6.78 (dd, J = 7.7, 7.7Hz, 1H), 3.94 (s, 3H), 2.27 (s, 3H). 
 
IR: 3145, 2954, 1670, 1613, 1461, 1289, 1247, 1144, 1083, 752 cm-1 
 
1H NMR 
 
70 
Methyl 5-acetyl-2-hydroxy-3-methylbenzoate 173 
 
 
 
To a suspension of AlCl3 (812 mg, 6.1 mmol) in CH2Cl2 (2 mL) was added 172 
(338 mg, 2 mmol). The reaction mixture was stirred under reflux for 30 minutes. The 
suspension was cooled to 0 °C and Ac2O (0.21 mL, 2.2 mmol) was added dropwise. 
The solution was stirred under reflux for 6 h. The resulting mixture was quenched 
with water and neutralized with aq. NaHCO3. The organic layer was extracted with 
CH2Cl2 (3x), washed with brine and dried over MgSO4. The solvent was removed by 
rotary evaporation to the crude product 173 (389 mg, 92%) as a clear liquid and was 
used in the next step without further purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 11.49 (s, 1H), 8.34 (d, J = 2.4 Hz, 1H), 7.96 (m, 
1H), 3.99 (s, 3H), 2.57 (s, 3H), 2.31 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 196.2, 170.6, 163.9, 135.8, 129.1, 128.3, 127.3, 
111.2, 52.6, 29.2, 15.7 ppm 
 
IR: 2955, 1738, 1672, 1444, 1349, 1288, 1233, 1149, 973, 745 cm-1 
 
HRMS: calculated for C11H12O4Na
+: 231.0628; found: 231.0626 
 
71 
1H NMR 
 
 
Methyl 5-acetoxy-2-hydroxy-3-methylbenzoate 174 
 
 
 
To a solution of 173 (389 mg, 1.87 mmol) in CH2Cl2 (2 mL) was added pTsOH.H2O 
(9 mg, 0.05 mmol) and mCPBA (645 mg, 3.74 mmol) in small portions. The reaction 
mixture was stirred under reflux for 22 h. The solution was quenched with 
aq. NaHCO3, extracted with CH2Cl2 (3x), washed with brine and dried over MgSO4. 
The solvent was removed by rotary evaporation to the crude product 174 (402 mg, 
86%) as a clear liquid and was used in the next step without further purification. 
 
72 
1H NMR (400 MHz, CDCl3):  (ppm) 10.91 (s, 1H), 7.41 (d, J = 3.0 Hz, 1H), 7.06 (d, 
J = 2.7 Hz, 1H), 3.93 (s, 3H), 2.27 (s, 3H), 2.26 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 170.3, 169.9, 157.9, 141.7, 129.9, 128.2, 119.4, 
111.5, 52.4, 21.0, 15.8 ppm 
 
IR: 3150, 1753, 1675, 1474, 1438, 1344, 1269, 1216, 1029, 792 cm-1 
 
HRMS: calculated for C11H12O5Na
+: 247.0577; found: 247.0584 
 
1H NMR 
 
73 
Methyl 2,5-dihydroxy-3-methylbenzoate 175 
 
 
 
To a suspension of 174 (1.48 g, 6.61 mmol) in MeOH (66 mL) was added nBu2SnO 
(164 mg, 0.66 mmol). The reaction mixture was stirred under reflux for 3 h. The 
solution was quenched with aq. NaHCO3, extracted with EtOAc (3x), washed with 
brine, dried over MgSO4 and filtered through a pad of Celite. The solvent was 
removed by rotary evaporation to the crude product 175 (1.20 mg, 97%) as a pale 
yellow solid and was used in the next step without further purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 10.58 (s, 1H), 7.12 (d, J = 3.1 Hz, 1H), 6.90 (d, 
J = 3.0 Hz, 1H), 4.35 (s, 1H), 3.93 (s, 3H), 2.24 (s, 3H). 
 
IR: 3428, 1677, 1607, 1441, 1357, 1213, 1126, 905, 730, 668 cm-1 
 
1H NMR 
74 
Methyl DA adduct 176 
 
 
 
To a suspension of 175 (3.3 g, 18.11 mmol) and 1-tert-buthyldimethylsiloxypenta-1,3-
diene (155) (11.5 g, 57.97 mmol, mixture of stereoisomers) in toluene (18 mL) at 
10 °C was added silver(I)oxide (8.40 g, 32.2 mmol) in one portion. The mixture was 
warmed to room temperature and stirred for 19 h, then was diluted with diethyl ether, 
and filtered through Celite. The Celite was washed thoroughly with diethyl ether, and 
the filtrate was concentrated in vacuo. The residue was purified by column 
chromatography (hexane/EtOAc, 10:1) to give 176 (5.91 g, 86%) of as a pale green 
solid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.63 (m, 1H), 5.68 (m, 2H), 4.78 (m, 1H), 3.76 
(s, 3H), 3.62 (d, J = 4.9 Hz, 1H), 2.15 (m, 1H) 1.94 (d, J = 1.5 Hz, 3H), 1.42 (d, 
J = 7.6 Hz, 3H), 0.74 (s, 9H), 0.02 (s, 3H), -0.11 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 196.5, 195.9, 169.7, 146.8, 141.5, 132.8, 126.0, 
67.2, 65.8, 52.9, 50.7, 29.9, 25.5, 17.8, 17.3, 15.8, -4.7, -5.2 ppm. 
 
IR: 2927, 2856, 2361, 1750, 1705, 1682, 1468, 1258, 1227, 1055 cm-1 
 
HRMS: calculated for C20H30O5SiNa
+: 401.1755; found: 401.1754 
 
75 
1H NMR 
 
 
13C NMR 
 
76 
Epi-methyl DA adduct 176 
 
 
 
A mixture of 176 (5.91 g, 15.61 mmol) and neutral alumina (156 g Brockman 
Activity II, M70 – 220) in toluene (470 mL) was stirred for 4 h at room temperature. 
The resulting mixture was filtered and washed with EtOAc. Concentration of the 
filtrate afforded 177 (5.71 g, 97%) of as a pale green solid and was used in the next 
step without further purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.71 (q, J = 1.5 Hz, 1H), 5.81 (ddd, J = 10.1, 5.6, 
2.0 Hz, 1H), 5.34 (dd, J = 9.9, 3.0 Hz, 1H), 5.04 (d, J = 5.5 Hz, 1H), 3.60 (s, 3H), 3.31 
(d, J = 9.3 Hz, 1H), 2.83 (m, 1H), 1.96 (d, J = 1.5 Hz, 3H), 1.21 (d, J = 6.8 Hz, 3H), 
0.81 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 197.7, 192.0, 167.4, 146.7, 139.6, 136.3, 125.8, 
67.4, 65.4, 53.0, 50.4, 30.0, 25.6, 20.8, 17.8, 16.2, -4.0, -5.0 ppm. 
 
IR: 2954, 2928, 2855, 2349, 1734, 1687, 1461, 1251, 1072, 838, 632 cm-1 
 
HRMS: calculated for C20H30O5SiNa
+: 401.1755; found: 401.1747 
 
77 
1H NMR 
 
 
13C NMR 
 
78 
Diketones 178a and 178b 
 
 
 
To a solution of 177 (100 mg, 0.26 mmol) in acetic acid (95%) (1 mL) was added zinc 
powder (34.5 mg, 0.53 mmol). After stirring for 2 h at room temperature, the resulting 
solution was treated with water and aq. NaHCO3, extracted with CH2Cl2 (3x), washed 
with brine and dried over MgSO4. The solvent was removed by rotary evaporation. 
The residue was purified by column chromatography (hexane/EtOAc, 6:1) to give 178 
(63 mg, 64%) as a 1:1 mixture of diastereomers. 
 
Diketone 178a: 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.78 (ddd, J = 9.7, 5.7, 2.0 Hz, 1H), 5.60 (dd, 
J = 9.8, 3.0 Hz, 1H), 4.95 (d, J = 5.6 Hz, 1H), 3.62 (s, 3H), 3.19 (d, J = 8.8 Hz, 1H), 
2.91 (m, 1H), 2.81 (m, 2H), 2.49 (dd, J = 16.3, 6.4 Hz, 1H), 1.26 (d, J = 7.1 Hz, 3H), 
1.17 (d, J = 6.8 Hz, 3H), 0.84 (s, 9H), 0.13 (s, 3H), 0.11 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 206.5, 203.0, 167.8, 136.2, 126.0, 67.8, 65.9, 52.9, 
49.9, 43.9, 42.4, 30.4, 25.8, 21.1, 17.9, 17.7, -4.3, -4.6 ppm. 
 
IR: 3383, 2928, 2855, 1770, 1641, 1471, 1250, 1063, 836, 633 cm-1 
 
HRMS: calculated for C20H32O5SiNa
+: 403.1912; found: 403.1925 
 
79 
Hydroxyketone 182 and diol 183 
 
 
 
To a solution of 177 (100 mg, 0.26 mmol) in MeOH (3.5 mL) was added NaBH4 
(100 mg, 2.64 mmol) at 0 °C. The reaction mixture was stirred for 2 h at 0 °C. The 
resulting mixture was quenched with aq. ammonium chloride, extracted with CH2Cl2 
(3x), washed with brine and dried over MgSO4. The solvent was removed by rotary 
evaporation. The residue was purified by column chromatography (hexane/EtOAc, 
3:1) to give 182 (25 mg, 25%) and 183 (30 mg, 30%). 
 
Hydroxyketone 182 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.73 (ddd, J = 9.7, 5.4, 2.3 Hz, 1H); 5.62 (dd, 
J = 9.6, 2.5 Hz, 1H); 5.46 (d, J = 9.1 Hz, 1H); 4.91 (d, J = 5.6 Hz, 1H), 4.25 (m, 1H), 
3.65 (s, 3H), 2.80 (m, 1H), 2.71 (m, 1H), 2.57 (dd, J = 10.9, 3.8 Hz, 1H), 2.27 (ddd, 
J = 13.8, 5.2, 3.4 Hz, 1H), 2.10 (d, J = 1.5 Hz, 1H), 1.44 (dt, J = 13.8, 2.5 Hz, 1H), 
1.10 (d, J = 6.8 Hz, 3H), 1.03 (d, J = 6.6 Hz, 3H), 0.80 (s, 9H), 0.12 (s, 3H), 0.09 (s, 
3H). 
 
13C NMR (100 MHz, CDCl3):  = 204.0, 172.0, 137.5, 127.1, 67.9, 66.7, 63.8, 53.5, 
45.3, 41.5, 36.5, 31.4, 25.7, 18.8, 17.8, 14.4,-4.0, -4.9 ppm. 
 
IR: 3434, 2953, 2856, 1694, 1438, 1249, 1074, 837, 774, 669 cm-1 
 
HRMS: calculated for C20H34O5SiNa
+: 405.2068; found: 405.2066 
 
80 
Diol 183 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.77 (m, 2H); 4.86 (m, 1H); 4.5 (d, J = 9.8 Hz, 
1H); 4.20 (m, 1H), 3.70 (d, J = 8.8 Hz, 1H), 3.68 (s, 3H), 3.55 (t, J = 9.0 Hz, 1H), 2.71 
(m, 1H), 2.32 (ddd, J = 14.6, 8.6, 4.5 Hz, 1H), 2.21 (dd, J = 10.4, 5.0 Hz, 1H), 1.79 
(m, 1H), 1.24 (m, 1H), 1.09 (d, J = 6.8 Hz, 3H), 0.97 (d, J = 6.8 Hz, 3H), 0.89 (s, 9H), 
0.17 (s, 3H), 0.11 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 177.6, 140.3, 125.6, 79.5, 69.5, 64.4, 55.1, 52.7, 
39.8, 39.5, 33.0, 30.7, 25.8, 18.7, 18.2, 17.9, -2.7, -4.3 ppm. 
 
IR: 3397, 2953, 2928, 2856, 1698, 1435, 1251, 1044, 835, 777 cm-1 
 
HRMS: calculated for C20H36O5SiNa
+: 407.2225; found: 407.2228 
 
Allylic alcohol 181 and 184 
 
 
 
To a solution of 177 (200 mg, 0.53 mmol) and CeCl37 H2O (413 mg, 1.11 mmol) in 
MeOH (7.5 mL) was added NaBH4 (60 mg, 1.59 mmol) at 0 °C. The reaction mixture 
was stirred for 2 h at 0 °C. The resulting mixture was quenched with aq. ammonium 
chloride, extracted with CH2Cl2 (3x), washed with brine and dried over MgSO4. The 
solvent was removed by rotary evaporation. The residue was purified by column 
chromatography (hexane/EtOAc, 6:1) to give 181 (108 mg, 54%) and 182 (80 mg; 
39%). 
 
81 
Allylic alcohol 181 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.92 (dq, J = 5.8, 1.3 Hz, 1H); 5.78 (ddd, J = 9.8, 
5.3 Hz, 2.3 Hz, 1H); 5.68 (dd, J = 9.8, 2.3 Hz, 1H); 5.00 (d, J = 5.3 Hz, 1H), 4.77 (d, 
J = 11.3 Hz, 1H), 4.42 (m, 1H), 3.67 (s, 3H), 2.68 (dd, J = 10.8, 5.3 Hz, 1H), 2.60 (m, 
1H), 1.81 (t, J = 1.1 Hz, 3H), 1.14 (d, J = 6.8 Hz, 3H), 0.77 (s, 9H), 0.08 (s, 3H), 0.06 
(s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 192.7, 171.6, 145.6, 137.0, 134.5, 126.7, 66.7, 63.3, 
61.3, 53.4, 40.2, 30.5, 25.6, 18.4, 18.0, 16.4, -4.0, -5.1 ppm. 
 
IR: 3443, 2954, 2856, 1676, 1435, 1251, 1067, 859, 837, 778 cm-1 
 
HRMS: calculated for C20H32O5SiNa
+: 403.1912; found: 403.1922 
 
Allylic alcohol 184 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.64 (m, 1H), 5.78 (dd, J = 9.9 Hz, 5.6, 2.3 Hz, 
1H); 5.57 (dd, J = 9.9, 2.5 Hz, 1H); 5.09 (m, 1H), 4.96 (d, J = 5.3 Hz, 1H), 3.59 (s, 
3H), 2.59 (m, 1H), 2.48 (t, J = 9.3 Hz, 1H), 1.78 (t, J = 1.5 Hz, 3H), 1.63 (d, 
J = 8.6 Hz, 1H), 1.31 (d, J = 6.8 Hz, 3H), 0.79 (s, 9H), 0.09 (s, 3H), 0.07 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 192.5, 168.8, 149.0, 137.4, 133.8, 126.3, 70.3, 66.3, 
63.5, 52.4, 46.2, 35.3, 25.8, 22.0, 17.9, 15.9, -4.1, -5.0 ppm. 
 
IR: 2953, 2855, 1727, 1675, 1462, 1360, 1250, 1075, 838, 631 cm-1 
 
HRMS: calculated for C20H32O5SiNa
+: 403.1912; found: 403.1904 
 
82 
Diallylic alcohol 180 
 
 
 
To a solution of 177 (100 mg, 0.26 mmol) in CH2Cl2 (1 mL) was added DIBAL 
(0.78 mL, 1 M in toluene, 0.78 mmol) dropwise at -78 °C under an argon atmosphere. 
The reaction mixture was stirred at -78 °C for 1 h and quenched with MeOH. After 
15 min the resulting mixture was warmed to room temperature, diluted with water and 
aq. Na,K- tartrate, extracted with diethyl ether (2x) and CH2Cl2 (1x), washed with 
brine and dried over MgSO4. The solvent was removed by rotary evaporation. The 
residue was purified by column chromatography (hexane/EtOAc, 10:1) to give 180 
(51 mg, 51%) as a white solid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.87 (dd, J = 10.0, 3.16 Hz, 1H), 5.68 (m, 2H), 
5.26 (d, J = 0.5 Hz, 1H); 4.72 (d, J = 5.3 Hz, 1H), 4.37 (s, 1H), 4.32 (m, 1H), 3.63 (s, 
3H), 2.97 (m, 1H), 2.44 (dd, J = 9.8, 7.1 Hz, 1H), 1.82 (t, J = 1.5 Hz, 3H), 1.17 (d, 
J = 6.8 Hz, 3H), 0.91 (s, 9H), 0.22 (s, 3H), 0.16 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 175.1, 140.3, 135.0, 128.9, 124.0, 73.1, 71.0, 63.3, 
52.6, 52.5, 34.6, 28.7, 25.7, 21.8, 19.8, 17.9, -3.2, -4.5 ppm. 
 
IR: 2925, 2356, 2341, 1743, 1714, 1674, 990, 753, 648, 620 cm-1 
 
HRMS: calculated for C20H34O5SiNa
+: 405.2068; found: 420.2061 
 
83 
1H NMR 
 
 
13C NMR 
 
84 
Allylic alcohol 184 
 
 
 
To a solution of 177 (50 mg, 0.13 mmol) in iPrOH (0.6 mL) was added Al(OiPr)3 
(120 mg, 0.59 mmol). The mixture was boiled gently, and acetone and iPrOH were 
distilled slowly from the reaction mixture through a short column. From time to time 
iPrOH was added to maintain a constant volume. After 18 h the reaction mixture was 
concentrated under reduced pressure, treated with 1 M HCl, and extracted with 
CH2Cl2 (3x). The organic layer was washed with sat. NaHCO3 and brine, dried over 
MgSO4 and concentrated in vacuo. The residue was purified by column 
chromatography (hexane/EtOAc, 10:1) to give 184 (21 mg, 41%) as a withe solid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.64 (m, 1H), 5.78 (dd, J = 9.9 Hz, 5.6, 2.3 Hz, 
1H); 5.57 (dd, J = 9.9, 2.5 Hz, 1H); 5.09 (m, 1H), 4.96 (d, J = 5.3 Hz, 1H), 3.59 (s, 
3H), 2.59 (m, 1H), 2.48 (t, J = 9.3 Hz, 1H), 1.78 (t, J = 1.5 Hz, 3H), 1.63 (d, 
J = 8.6 Hz, 1H), 1.31 (d, J = 6.8 Hz, 3H), 0.79 (s, 9H), 0.09 (s, 3H), 0.07 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 192.5, 168.8, 149.0, 137.4, 133.8, 126.3, 70.3, 66.3, 
63.5, 52.4, 46.2, 35.3, 25.8, 22.0, 17.9, 15.9, -4.1, -5.0 ppm. 
 
IR: 2953, 2855, 1727, 1675, 1462, 1360, 1250, 1075, 838, 631 cm-1 
 
HRMS: calculated for C20H32O5SiNa
+: 403.1912; found: 403.1904 
 
85 
Methyl lactone 185 
 
 
 
To a solution of 180 (100 mg, 0.27 mmol) in THF (4 mL) was added NaH (27 mg, 
60% in mineral oil, 0.68 mmol) at 0 °C. After stirring at room temperature for 1.5 h, 
the resulting solution was quenched with aq. ammonium chloride, extracted with 
EtOAc (3x), washed with brine and dried over MgSO4. The solvent was removed by 
rotary evaporation to the crude product 185 (90 mg, 95%) as a clear liquid and was 
used in the next step without further purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.06 (dq, J = 5.6, 1.6 Hz, 1H), 5.70 (dt, J = 10.3, 
2.52 Hz, 1H), 5.64 (dt, J = 10.3, 2.0 Hz, 1H), 4.80 (m, 2H), 4.54 (d, J = 5.8 Hz, 1H), 
4.23 (s, 1H), 2.38 (d, J = 9.8 Hz, 1H), 1.90 (m, 1H), 1.80 (d, J = 1.5 Hz, 3H), 1.16 (d, 
J = 7.0 Hz, 3H), 0.95 (s, 9H), 0.27 (s, 3H), 0.22 (s, 3H). 
 
1H NMR 
 
86 
Methyl lactol 186 
 
 
 
To a solution of 185 (45 mg, 0.13 mmol) in CH2Cl2 (1 mL) was added DIBAL 
(0.55 mL, 1 M in toluene, 0.55 mmol) dropwise at -78 °C under an argon atmosphere. 
The reaction mixture was stirred at -78 °C for 1 h and quenched with MeOH. After 
15 min the resulting mixture was warmed to room temperature, diluted with water and 
aq. Na,K- tartrate, extracted with diethyl ether (2x) and CH2Cl2 (1x), washed with 
brine and dried over MgSO4. The solvent was removed by rotary evaporation. The 
residue was purified by column chromatography (hexane/EtOAc, 3:1) to give 186 
(28 mg, 61%) in a 1:1 mixture of diastereomers. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.99 (m, 1H), 5.88 (m, 1H), 5.71 (m, 4H), 5.04 
(m, 2H), 4.75 (d, J = 8.8 Hz, 1H), 4.68 (q, J = 2.3 Hz, 1H), 4.64 (d, J = 1.5 Hz, 1H), 
4.41 (m, 1H), 4.39 (d, J = 1.0 Hz, 1H), 4.22 (d, J = 5.8 Hz, 1H), 4.11 (d, J = 5.8 Hz, 
1H), 4.02 (d, J = 1.0 Hz, 1H), 2.44 (m, 1H), 2.33 (m, 1H), 2.22 (d, J = 9.1 Hz, 1H), 
2.11 (d, J = 9.3 Hz, 1H), 2.03 (m, 2H), 1.84 (d, J = 1.5 Hz, 3H), 1.78 (d, J = 1.5 Hz, 
3H), 1.12 (d, J = 2.5 Hz, 3H), 1.11 (d, J = 2.5 Hz, 3H), 0.95 (s, 18H), 0.23 (s, 3H), 
0.20 (s, 3H) 0.20 (s, 3H), 0.19 (s, 3H). 
 
87 
Diketone epoxide 189 
 
 
 
To a solution of 177 (4.0 g, 11 mmol) in MeOH (110 mL) was added aq. NaOH 10% 
(2.1 mL) and H2O2 30 wt.% (4.1 mL, 53 mmol) at 0°C. The reaction mixture was 
stirred for 1 h at 0 °C. The resulting mixture was quenched with sodium thiosulfate, 
extracted with diethyl ether (3x), washed with brine and dried over MgSO4. The 
solvent was removed by rotary evaporation to the crude product 189 (1.20 mg, 97%) 
as a white solid and was used in the next step without further purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.77 (ddd, J = 9.8, 5.1, 2.4 Hz, 1H), 5.56 (dd, 
J = 9.7, 2.2 Hz, 1H), 4.85 (d, J = 5.2 Hz, 1H), 3.77 (d, J = 10.3 Hz, 1H), 3.59 (s, 3H), 
3.54 (s, 1H), 2.42 (m, 1H), 1.52 (s, 1H), 1.09 (d, J = 6.6 Hz, 3H), 0.86 (s, 9H), 0.08 (s, 
6H). 
 
13C NMR (100 MHz, CDCl3):  = 203.1, 197.4, 167.4, 134.9, 126.1, 67.3, 66.9, 66.5, 
62.3, 52.7, 44.5, 28.7, 25.5, 19.6, 17.8, 16.2, -3.8, -5.3 ppm. 
 
IR: 2956, 2929, 2857, 2367, 1757, 1733, 1715, 1076, 839, 778 cm-1 
 
HRMS: calculated for C20H30O6SiNa
+: 417.1704; found: 417.1706 
 
88 
1H NMR 
 
 
13C NMR 
 
89 
Dihydroxy epoxide 190 
 
 
 
To a solution of 189 (100 mg, 0.25 mmol) in MeOH (3.6 mL) was added NaBH4 
(29 mg, 0.76 mmol) at 0 °C. The reaction mixture was stirred for 1.5 h at 0 °C. The 
resulting mixture was quenched with aq. ammonium chloride, extracted with diethyl 
ether (3x), washed with brine and dried over MgSO4. The solvent was removed by 
rotary evaporation. The residue was purified by column chromatography 
(hexane/EtOAc, 3:1) to give 190 (100 mg, 99%) as a clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.80 (ddd, J = 9.8, 5.6, 2.0 Hz, 1H), 5.64 (dd, 
J = 9.8, 2.8 Hz, 1H), 4.97 (d, J = 9.8 Hz, 1H), 4.82 (d, J = 5.3 Hz, 1H), 4.38 (m, 1H), 
4.16 (d, J = 10.6 Hz, 1H), 4.01 (d, J = 10.6 Hz, 1H), 3.67 (s, 3H), 3.31 (d, J = 3.0 Hz, 
1H), 2.61 (m, 1H), 2.51 (dd, J = 10.8, 4.3 Hz, 1H), 1.44 (s, 3H), 1.06 (d, J = 6.8 Hz, 
3H), 0.91 (s, 9H), 0.16 (s, 3H), 0.09 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 177.0, 139.0, 126.9, 73.2, 68.0, 64.5, 63.8, 59.9, 
54.4, 52.9, 35.7, 30.3, 25.7, 21.4, 18.5, 17.9, -2.6, -4.5 ppm. 
 
HRMS: calculated for C20H34O6SiNa
+: 421.2017; found: 421.2023 
 
90 
1H NMR 
 
 
13C NMR 
 
91 
Epoxy-lactone 191 
 
 
 
To a solution of 190 (100 mg, 0.25 mmol) in THF (2.5 mL) was added NaH (25 mg, 
60% in mineral oil, 0.63 mmol) at 0 °C. After stirring for 1.5 h at 0 °C, the resulting 
solution was quenched with aq. ammonium chloride, extracted with CH2Cl2 (3x), 
washed with brine and dried over MgSO4. The solvent was removed by rotary 
evaporation. The residue was purified by column chromatography (hexane/EtOAc, 
3:1) to give 191 (76 mg, 84%) as a clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.64 (m, 2H), 4.81 (d, J = 3.5 Hz, 1H), 4.75 (d, 
J = 1.8 Hz, 1H), 4.67 (m, 1H), 4.06 (d, J = 4.1 Hz, 1H), 3.39 (d, J = 3.5 Hz, 1H), 2.41 
(d, J = 9.6 Hz, 1H), 1.87 (m, 1H), 1.47 (s, 3H), 1.15 (d, J = 6.8 Hz, 3H), 0.95 (s, 9H), 
0.27 (s, 3H), 0.20 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 177.0, 134.2, 129.5, 79.8, 70.2, 68.2, 58.9, 58.6, 
55.6, 37.6, 27.9, 25.7, 19.4, 17.9, -4.5, -4.9 ppm. 
 
IR: 3467, 2927, 2856, 2362, 1776, 1463, 1258, 1075, 1000, 848 cm-1 
 
HRMS: calculated for C19H30O5SiNa
+: 389.1755; found: 389.1765 
 
92 
1H NMR 
 
 
13C NMR 
 
93 
Acetal 192 
 
 
 
To a solution of 191 (30 mg, 0.082 mmol) in CH2Cl2 (0.8 mL) was added DIBAL 
(0.14 mL, 1.5 M in toluene, 0.20 mmol) dropwise at -78 °C under an argon 
atmosphere. The reaction mixture was stirred at -78 °C for 1 h and quenched with 
MeOH. After 15 min the resulting mixture was warmed to room temperature, diluted 
with water and aq. Na,K- tartrate, extracted with diethyl ether (2x) and CH2Cl2 (1x), 
washed with brine and dried over MgSO4. The solvent was removed by rotary 
evaporation. The residue was purified by column chromatography (hexane/EtOAc, 
3:1) to give 192 (11 mg, 36%) as clear oil. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.88 (dd, J = 10.1, 3.8 Hz, 1H ), 5.75 (ddd, 
J = 10.2, 5.4, 2.0 Hz, 1H); 4.97 (s, 1H); 4.25 (d, J = 5.2 Hz, 1H), 4.19 (d, J = 4.0 Hz, 
1H), 3.82 (m, 1H), 3.67 (m, J = 11.4, 3.9, 2.3 Hz, 1H), 3.41 (d, J = 11.5 Hz, 1H), 2.97 
(d, J = 1.0 Hz, 1H), 2.59 (d, J = 5.2 Hz, 1H), 2.19 (m, 1H), 1.45 (s, 3H), 1.16 (d, 
J = 7.2 Hz, 3H), 0.90 (s, 9H), 0.15 (s, 3H), 0.12 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 138.9, 123.9, 105.1, 84.4, 82.7, 79.1, 72.2, 68.2, 
57.9, 38.5, 31.6, 25.9, 22.1, 18.6, 17.9, -3.7, -4.6 ppm. 
 
HRMS: calculated for C19H32O5SiNa
+: 391.1912; found: 391.1907 
 
94 
1H NMR 
 
 
13C NMR 
 
95 
Monohydroxy epoxide 193 
 
 
 
To a solution of 189 (4.12 g, 11 mmol) and CeCl37 H2O (8.61 g, 23.1 mmol) in 
MeOH (150 mL) was added NaBH4 (1.25 g, 33 mmol) at 0 °C. The reaction mixture 
was stirred for 1 h at 0 °C. The resulting mixture was quenched with aq. ammonium 
chloride, extracted with CH2Cl2 (3x), washed with brine and dried over MgSO4. The 
solvent was removed by rotary evaporation. The residue was purified by column 
chromatography (hexane/EtOAc, 3:1) to give 193 (3.73 g, 85%) as a withe solid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.72 (ddd, J = 9.8, 5.1, 2.3 Hz, 1H), 5.64 (dd, 
J = 9.8, 2.0 Hz, 1H), 4.98 (d, J = 11.0 Hz, 1H), 4.86 (d, J = 5.0 Hz, 1H), 4.54 (m, 1H), 
3.70 (s, 3H), 3.58 (d, J = 2.9 Hz, 1H), 2.76 (dd, J = 11.3, 4.3 Hz, 1H), 2.38 (m, 1H), 
1.44 (s, 3H), 1.12 (d, J = 6.9 Hz, 3H), 0.83 (s, 9H), 0.05 (s, 3H), 0.03 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 200.8, 172.2, 137.0, 126.9, 67.9, 63.9, 63.6, 63.5, 
58.8, 53.6, 37.4, 30.1, 25.5, 18.3, 17.8, 16.3, -3.9, -5.2 ppm. 
 
IR: 2428, 2955, 2917, 2875, 1697, 1659, 1543, 1419, 1264, 1078 cm-1 
 
HRMS: calculated for C20H32O6SiNa
+: 419.1861; found: 419.1864 
 
96 
1H NMR 
 
 
13C NMR 
 
97 
MOM-epoxide 194 
 
 
 
To a solution of 193 (3.73 g, 9.4 mmol) in CH2Cl2 (9 mL) was successively added 
DIPEA (4 mL, 23.5 mmol) and MOMCl (3.6 mL, 47 mmol) dropwise at 0 °C. The 
reaction mixture was warmed to room temperature and stirred for 16 h. The resulting 
mixture was quenched with water, extracted with CH2Cl2 (3x), washed with brine and 
dried over MgSO4. The solvent was removed by rotary evaporation to the crude 
product 194 (4.02 mg, 97%) as clear oil. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.73 (m, 2H), 4.72 (m, 2H), 4.56 (d, J = 4.4 Hz, 
1H), 4.40 (m, 1H), 3.59 (d, J = 3.2 Hz, 1H), 3.56 (s, 3H), 3.38 (s, 3H), 2.59 (dd, 
J = 10.8, 3.1 Hz, 1H), 2.45 (m, 1H), 1.51 (s, 3H), 1.07 (d, J = 6.9 Hz, 3H), 0.81 (s, 
9H), 0.05 (s, 3H), 0.04 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 200.0, 169.8, 136.0, 125.5, 98.1, 72.3, 66.3, 60.6, 
59.3, 59.2, 55.4, 51.8, 37.8, 29.1, 25.6, 18.4, 16.3, -3.7, -5.3 ppm. 
 
IR: 2951, 2929, 2855, 2373, 1748, 1719, 1066, 1045, 724, 630 cm-1 
 
HRMS: calculated for C22H36O7SiNa
+: 463.2123; found: 463.2113 
 
98 
1H NMR 
 
 
13C NMR 
 
99 
Primary alcohol 195 
 
 
 
To a solution of 194 (1.0 g, 2.27 mmol) in CH2Cl2 (9 mL) was added DIBAL (4.54 mL, 
1.5 M in toluene, 6.81 mmol) dropwise at -78 °C under an argon atmosphere. The 
reaction mixture was stirred at -78 °C for 1 h and quenched with MeOH. After 15 min 
the resulting mixture was warmed to room temperature, diluted with water and aq. 
Na,K- tartrate, extracted with diethyl ether (2x) and CH2Cl2 (1x), washed with brine 
and dried over MgSO4. The solvent was removed by rotary evaporation. The residue 
was purified by column chromatography (hexane/EtOAc, 3:1) to give 195 (880 mg, 
95%) as a withe solid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.64 (m, 2H), 4.88 (d, J = 7.1 Hz, 1H), 4.84 (d, 
J = 7.1 Hz, 1H), 4.56 (m, 1H), 4.24 (m, 1H), 3.89 (dd, J = 12.1, 2.0 Hz, 1H), 3.57 (dd, 
J = 11.5, 2.0 Hz, 1H), 3.53 (d, J = 3.0 Hz, 1H), 3.43 (s, 3H), 3.40 (m, 1H), 2.70 (dd, 
J = 11.1, 3.5 Hz, 1H), 2.42 (m, 1H), 1.45 (s, 3H), 1.11 (d, J = 6.9 Hz, 1H), 0.82 (s, 
9H), 0.02 (s, 3H), 0.02 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 206.5, 136.1, 126.3, 97.7, 72.7, 67.9, 64.7, 60.4, 
60.0, 56.1, 55.4, 36.4, 28.8, 25.6, 18.2, 17.8, 15.7, -3.8, -5.2 ppm. 
 
IR: 3469, 2930, 2856, 2364, 1713, 1250, 1077, 1032, 764, 630 cm-1 
 
HRMS: calculated for C21H36O6SiNa
+: 435.2174; found: 435.2173 
 
100 
1H NMR 
 
 
13C NMR 
 
101 
Aldehyde 196 
 
 
 
To a solution of 195 (880 mg, 2.13 mmol) in EtOAc (21 mL) was added IBX (1.79 g, 
6.40 mmol). The reaction mixture was stirred under reflux for 10 h. The resulting 
mixture was cooled to room temperature and filtered through a pad of Celite. The 
Celite was washed thoroughly with diethyl ether, and the filtrate was concentrated in 
vacuo. The residue was purified by column chromatography (hexane/EtOAc, 3:1) to 
give 196 (701 mg, 80%) as a white solid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 9.52 (s, 1H), 5.75 (ddd, J = 9.9, 5.1, 2.1 Hz, 1H), 
5.69 (dd, J = 9.9, 1.9 Hz, 1H), 4.77 (m, 2H), 4.53 (m, 2H), 3.65 (d, J = 3.4 Hz, 1H), 
3.35 (s, 3H), 2.81 (dd, J = 11.2, 2.4 Hz, 1H), 2.53 (m, 1H), 1.46 (s, 3H), 1.14 (d, 
J = 6.9 Hz, 3H), 0.82 (s, 9H), 0.04 (s, 3H), 0.02 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 200.1, 197.0, 136.0, 126.4, 97.4, 72.6, 67.2, 67.1, 
61.2, 60.1, 55.7, 37.8, 29.3, 35.5, 18.9, 17.8, 15.9, -3.9, -5.3 ppm. 
 
IR: 2951, 2930, 2855, 2364, 1725, 1692, 1253, 1072, 1042, 838 cm-1 
 
HRMS: calculated for C21H34O6SiNa
+: 433.2017; found: 433.2011 
 
102 
1H NMR 
 
 
13C NMR 
 
103 
Homoallylic OTBS ether 198 
 
 
 
To a solution of 196 (500 mg, 1.22 mmol) and AllylSnBu3 (0.4 mL, 1.23 mmol) in 
CH2Cl2 (12 mL) was added BF3OEt2 (190 µL, 0.73 mmol) at -78 °C under an argon 
atmosphere. After stirring at -78 °C for 1 h the reaction mixture was allowed to warm 
up slowly to 0 °C. The resulting solution was quenched with aq. NaHCO3, extracted 
with CH2Cl2 (3x), washed with brine and dried over MgSO4. The solvent was 
removed by rotary evaporation. The residue was purified by column chromatography 
(hexane/EtOAc, 3:1) to give 198 (265 mg, 48%) of as clear oil. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.83 (ddd, J = 9.7, 5.7, 2.1 Hz, 1H), 5.74 (m, 
2H), 5.08 (s, 1H), 5.05 (m, 1H), 4.79 (d, J = 7.1 Hz, 1H), 4.66 (d, J = 7.1 Hz, 1H), 
4.26 (dd, J = 8.0, 4.2 Hz, 1H), 4.16 (d, J = 5.7 Hz, 1H), 3.89 (dd, J = 6.1, 1.1 Hz, 1H), 
3.44 (s, 3H), 3.02 (m, 1H), 2.79 (dd, J = 8.6, 6.2 Hz, 1H), 2.14 (m, 1H), 1.96 (m, 1H), 
1.60 (s, 1H), 1.31 (s, 3H), 1.10 (d, J = 7.0 Hz, 3H), 0.88 (s, 9H), 0.17 (s, 3H), 0.07 (s, 
3H). 
 
13C NMR (100 MHz, CDCl3):  = 210.7, 137.0, 133.9, 125.6, 118.0, 97.0, 81.0, 78.9, 
76.7, 75.6, 62.2, 56.1, 55.4, 45.6, 37.7, 28.5, 19.5, 17.0, -4.0, -4.7 ppm. 
 
IR: 3445, 2954, 2928, 2855, 1769, 1461, 1249, 1057, 835, 775 cm-1 
 
HRMS: calculated for C24H40O6SiNa
+: 475.2487; found: 475.2484 
 
104 
1H NMR 
 
 
13C NMR 
 
105 
Hydrated aldehyde 200 
 
 
 
To a solution of 196 (50 mg, 0.12 mmol) in EtOAc (1.2 mL) was added Pd/C (8 mg). 
The reaction mixture was stirred under hydrogen atmosphere (1 atm) for 1 h at room 
temperature. The resulting suspension was diluted with EtOAc and filtered through a 
pad of Celite. The solvent was removed by rotary evaporation to the crude product 
200 (50 mg, 99%) as a white solid and was used in the next step without further 
purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 9.82 (s, 1H), 4.77 (d, J = 7.0 Hz, 1H), 4.74 (d, 
J = 7.0 Hz, 1H), 4.50 (m, 2H), 3.57 (d, J = 3.2 Hz, 1H), 3.32 (s, 3H), 2.58 (dd, 
J = 11.8, 2.2 Hz, 1H), 2.07 (m, 1H), 1.61 (m, 4H), 1.43 (s, 3H), 1.01 (d, J = 6.3 Hz, 
3H), 0.83 (s, 9H), 0.04 (s, 3H), 0.00 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 199.6, 198.3, 97.4, 73.1, 69.6, 68.2, 60.6, 59.5, 
55.7, 39.2, 29.7, 29.2, 27.6, 25.7, 19.6, 18.0, 16.0, -4.5, -5.3 ppm.  
 
IR: 2931, 2857, 2360, 1732, 1698, 1463, 1254, 1042, 1022, 835 cm-1 
 
HRMS: calculated for C21H36O6SiNa
+: 435.2174; found: 435.2188 
106 
Homoallylic alcohol 201 and homoallylic OTBS 202 
 
 
 
To a solution of zinc chloride (0.19 mL, 1 M in diethyl ether 0.19 mmol) in THF 
(0.5 mL) was added allylmagnesium chloride at -78 °C. The suspension was stirred 
for 5 min and 200 (50 mg, 0.11 mmol) solved in THF (0.6 mL) was added via syringe. 
After stirring for 1 h at -78 °C the reaction mixture was allowed to warm up to room 
temperature. The mixture was stirred for 1 h at room temperature, quenched with 
ammonium chloride, extracted with diethyl ether (3x), washed with brine, dried over 
MgSO4 and concentrated in vacuo. The residue was purified by column 
chromatography (hexane/EtOAc, 6:1) to give 201 (11 mg, 20%) and 202 (10 mg, 
20%). 
 
Homoallyl alcohol 201: 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.82 (m, 1H), 5.03 (m, 2H), 4.88 (d, J = 7.0 Hz, 
1H), 4.83 (d, J = 7.0 Hz, 1H), 4.51 (m, 2H), 3.76 (ddd, J = 11.0, 5.5, 1.5 Hz, 1H), 3.49 
(d, J = 2.5 Hz, 1H), 3.42 (s, 3H), 3.72 (dd, J = 4.2, 1.2 Hz, 1H), 2.54 (ddt, J = 14.1, 
6.8, 1.4 Hz, 1H), 2.46 (dd, J = 11.8, 3.5 Hz, 1H), 2.21 (m, 1H),1.95 (m, 1H), 1.86 (m, 
1H),1.58 (m, 1H), 1.52 (m, 2H), 1.40 (s, 3H), 0.93 (d, J = 6.3 Hz, 1H), 0.83 (s, 9H), 
0.05 (s, 3H), 0.03 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 203.9, 136.8, 116.4, 97.7, 73.7, 72.3, 67.5, 59.6, 
58.8, 57.8, 56.0, 37.9, 35.6, 28.4, 28.4, 27.6, 25.8, 20.5, 18.0, 16.4, -4.2, -5.4 ppm. 
 
HRMS: calculated for C24H42O6SiNa
+: 477.2643; found: 477.2647 
 
107 
Homoallyl OTBS 202 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.80 (m, 1H), 5.08 (m, 2H), 4.78 (d, J = 7.0 Hz, 
1H), 4.67 (d, J = 7.0 Hz, 1H), 4.54 (dd, J = 8.2, 3.4 Hz, 1H), 4.17 (dd, J = 5.5, 1.5 Hz, 
1H), 4.10 (d, J = 3.5 Hz, 1H), 3.75 (dd, J = 5.5, 1.2 Hz, 1H), 3.42 (s, 3H), 2.40 (dd, 
J = 10.9, 5.4 Hz, 1H), 2.25 (m, 1H), 2.12 (m, 1H),1.95 (m, 1H), 1.64 (m, 2H),1.57 (d, 
J = 5.5 Hz, 1H), 1.44 (m, 2H), 1.26 (s, 3H), 0.95 (d, J = 6.3 Hz, 1H), 0.90 (s, 9H), 
0.18 (s, 3H), 0.07 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 210.4, 133.9, 118.1, 97.6, 80.1, 78.8, 78.4, 75.1, 
65.6, 55.8, 55.8, 47.5, 37.3, 29.8, 27.9, 27.3, 26.1, 19.9, 18.3, 17.1, -4.2, -4.8 ppm. 
 
HRMS: calculated for C24H42O6SiNa
+: 477.2643; found: 477.2644 
 
108 
Dienone 197 
 
 
 
To a solution of 195 (50 mg, 0.12 mmol) in THF (1.2 mL) was added NaH (10 mg, 
60% in mineral oil, 0.24 mmol) at 0 °C. After stirring at room temperature for 3 h, the 
resulting solution was quenched with aq. ammonium chloride, extracted with EtOAc 
(3x), washed with brine and dried over MgSO4. The solvent was removed by rotary 
evaporation to the crude product 197 (27 mg, 91%) as a clear liquid and was used in 
the next step without further purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.98 (m 1H), 6.02 (ddd, J = 9.5, 5.3, 2.8 Hz, 1H), 
5.96 (m, 1H), 4.76 (d, J = 7.0 Hz, 1H), 4.73 (d, J = 7.0 Hz, 1H), 4.24 (m, 1H), 3.79 (d, 
J = 4.0 Hz, 1H), 3.36 (s, 3H), 2.89 (dtd, J = 18.3, 3.0, 1.0 Hz, 1H), 2.77 (m, 1H), 1.52 
(s, 3H), 1.15 (d, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 195.2, 141.6, 131.8, 130.3, 122.8, 97.5, 72.5, 65.0, 
60.1, 55.6, 42.4, 29.4, 18.4, 15.7 ppm.  
 
IR: 2933, 2889, 1678, 1628, 1557, 1330, 1149, 1023, 920, 852 cm-1 
 
HRMS: calculated for C14H18O4SiNa
+: 273.1098; found: 273.1099 
 
109 
1H NMR 
 
 
13C NMR 
 
110 
Allylic acetate 212 
 
 
 
To a solution of 198 (20 mg, 0.044 mmol) in CH2Cl2 (0.4 mL) was added DMAP 
(0.5 mg, 0.004 mmol), acetic anhydride (42 µL, 0.44 mmol) and triethylamine (3 µL, 
0.022 mmol). The reaction mixture was stirred for 18 h at room temperature. The 
resulting solution was quenched with water, extracted with EtOAc (3x), washed with 
brine and dried over MgSO4. The solvent was removed by rotary evaporation. The 
residue was purified by column chromatography (hexane/EtOAc, 6:1) to give 212 
(12 mg, 55%) as a clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.83 (ddd, J = 9.8, 5.8, 2.0 Hz, 1H), 5.73 (m, 
2H), 5.18 (d, J = 1.2 Hz, 1H), 5.05 (m, 2H), 4.93 (d, J = 6.8 Hz, 1H), 4.68 (d, 
J = 7.0 Hz, 1H), 4.25 (dd, J = 8.5, 4.0 Hz, 1H), 4.15 (d, J = 5.8 Hz, 1H), 3.85 (dd, 
J = 6.3, 1.0 Hz, 1H), 3.44 (s, 3H), 3.05 (m, 1H), 2.71 (dd, J = 8.5, 6.3 Hz, 1H), 2.11 
(m, 1H), 2.01 (s, 3H), 1.95 (m, 1H), 1.89 (s, 3H), 1.09 (d, J = 7.0 Hz, 3H), 0.87 (s, 
9H), 0.18 (s, 3H), 0.07 (s, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 208.5, 169.5, 137.1, 133.8, 125.5, 118.0, 96.3, 80.0, 
76.5, 75.5, 73.0, 62.1, 56.4, 55.0, 45.4, 37.6, 28.5, 25.5, 20.9, 19.3, 18.0, 16.9, -3.8,  
-4.9 ppm.  
 
IR: 2924, 2852, 2364, 1771, 1744, 1644, 1224, 1028, 836, 722 cm-1 
 
HRMS: calculated for C26H42O7SiNa
+: 517.2592; found: 517.2595 
 
111 
Homoallylic alcohol 214 
 
 
 
To a solution of 198 (77 mg, 0.19 mmol) in MeOH (1.9 mL) was added sulfuric acid 
(30 µL, 0.56 mmol). The reaction mixture was stirred for 4 h at room temperature. 
The resulting solution was quenched with aq. NaHCO3, extracted with diethyl ether 
(3x), washed with brine and dried over MgSO4. The solvent was removed by rotary 
evaporation. The residue was purified by column chromatography (hexane/EtOAc, 
1:1) to give 214 (38 mg, 68%) as clear oil. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.89 (dd, J = 10.0, 2.6 Hz, 1H), 5.81 (m, 1H), 
5.73 (m, 1H), 5.12 (m, 2H), 4.31 (m, 2H), 4.00 (m, 1H), 3.92 (ddd, J = 11.4, 5.4, 
1.5 Hz, 1H), 3.31 (d, J = 11.4 Hz, 1H), 3.12 (m, 1H), 2.60 (dd, J = 9.9, 5.5 Hz, 1H), 
2.17 (m, 1H), 2.02 (m, 1H), 1.95 (m, 1H), 1.38 (s, 3H), 1.18 (d, J = 7.0 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 215.7, 139.2, 132.7, 123.0, 118.9, 83.3, 76.5, 70.9, 
62.8, 56.1, 53.4, 45.7, 37.5, 29.2, 19.2, 16.9, ppm. 
 
IR: 3375, 2923, 2356, 1752, 1642, 1415, 1378, 1224, 1054, 1021 cm-1 
 
HRMS: calculated for C16H22O5SiNa
+: 317.1360; found: 317.1362 
 
112 
1H NMR 
 
 
13C NMR 
 
113 
Triacetate 216 
 
 
 
To a solution of 215 (33 mg, 0.13 mmol) in CH2Cl2 (1.1 mL) was added DMAP 
(4.1 mg, 0.03 mmol), acetic anhydride (0.16 mL, 1.68 mmol) and triethylamine 
(18 µL, 0.13 mmol). The reaction mixture was stirred for 24 h at room temperature. 
The resulting solution was quenched with water, extracted with EtOAc (3x), washed 
with brine and dried over MgSO4. The solvent was removed by rotary evaporation to 
the crude product 216 (56 mg, 99%) as a clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.85 (m, 2H), 5.81 (m, 1H), 5.75 (m, 1H), 5.51 
(d, J = 5.6 Hz, 1H), 5.16 (m, 3H), 5.12 (m, 1H), 4.37 (dd, J = 8.3, 4.2 Hz, 1H), 2.64 
(m, 2H), 2.22 (s, 1H), 2.18 (s, 3H), 2.12 (s, 3H), 2.10 (m, 1H), 2.09 (s, 3H), 1.16 (s, 
3H), 1.07 (d, J = 6.6 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 207.5, 169.6, 168.6, 168.5, 139.0, 132.6, 121.5, 
119.0, 79.8, 75.7, 68.2, 63.0, 52.4, 45.9, 38.0, 29.2, 21.1, 21.0, 20.9, 19.3, 16.4 ppm. 
One quaternary carbon atom could not be assigned. 
 
IR: 3367, 2948, 2839, 2361, 2342, 1642, 1412, 1112, 1018, 669 cm-1 
 
HRMS: calculated for C22H28O8SiNa
+: 420.1784; found: 420.1669 
 
114 
1H NMR 
 
 
13C NMR 
 
115 
Tetracycle 216 and 217 
 
 
 
To a solution of 215 (56 mg, 0.13 mmol) in AcOH (3.25 mL) was added Pd(PPh3)4 
(15 mg, 0.001 mmol) under argon atmosphere. The reaction mixture was stirred at 
80 °C for 3 h. The resulting solution was diluted with water, quenched with water, 
extracted with diethyl ether (3x), washed with brine and dried over MgSO4. The 
solvent was removed by rotary evaporation. The residue was purified by column 
chromatography (hexane/EtOAc, 3:1) to give 216 and 217 (35 mg, 75%) as a 1:1 
mixture of double bond isomers. 
 
HRMS: calculated for C22H28O8SiNa
+: 383.1466; found: 383.1469 
 
116 
Hydrogenated tetracycle 218 
 
 
 
To a solution of 216 and 217 (35 mg, 0.097 mmol) in EtOAc (1.1 mL) was added 
Pd/C (8 mg). The reaction mixture was stirred under hydrogen atmosphere (1 atm) 
for 6 h at room temperature. The resulting suspension was diluted with EtOAc and 
filtered through a pad of Celite. The solvent was removed by rotary evaporation to 
the crude product 218 (28 mg, 79%) as a clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 5.18 (d, J = 1.2 Hz, 1H), 5.05 (dd, J = 8.1, 
6.7 Hz, 1H), 4.94 (dd, J = 4.8, 1.2 Hz, 1H), 2.45 (dt, J = 14.6, 8.6 Hz, 1H), 2.16 (s, 
3H), 2.07 (s, 3H), 2.07 (m, 1H), 1.88 (m, 1H), 1.82 (dd, J = 10.8, 4.8 Hz, 1H), 1.71 
(m, 1H), 1.64 (m, 2H), 1.20 (s, 3H), 1.02 (m, 3H), 0.95 (d, J = 7.2 Hz, 3H), 0.83 (d, 
J = 6.3 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3):  = 213.4, 169.6, 168.6, 80.7, 79.8, 79.5, 69.8, 60.5, 
51.8, 42.0, 41.3, 38.9, 33.3, 31.0, 29.9, 22.6, 21.0, 20.9, 19.5, 16.8 ppm.  
 
IR: 2927, 1743, 1484, 1449, 1373, 1234, 1153, 1033, 922, 861 cm-1 
 
HRMS: calculated for C22H28O8SiNa
+: 387.1779; found: 387.1779 
 
117 
1H NMR 
 
 
13C NMR 
 
118 
1,2,4-Trimethoxy-3-methylbenzene 230 
 
 
 
To a solution of nBuLi (11.4 mL, 2.5 M in toluene, 28.54 mmol) in THF (25 mL) was 
added 1,2,4-trimethoxybenzene 228 (4 g, 23.78 mmol) slowly under argon at room 
temperature (bubbler is required). After stirring for 1 h at room temperature, the 
suspension was cooled to -78 °C and methyl iodide (1.78 mL, 28.54 mmol) was 
added. The reaction mixture was stirred for 30 min at -78 °C. The mixture was 
allowed to warm up slowly to room temperature. The resulting solution was quenched 
with aq. ammonium chloride, extracted with diethyl ether (3x), washed with brine and 
dried over MgSO4. The solvent was removed by rotary evaporation. The residue was 
purified by column chromatography (hexane/EtOAc, 6:1) to give 230 (3.94 g, 91%) as 
clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.70 (d, J = 8.8 Hz, 1H), 6.54 (d, J = 8.8 Hz, 1H), 
3.82 (s, 3H), 3.80 (s, 3H), 3.78 (s, 3H), 2.16 (s, 3H). 
 
1H NMR 
 
119 
2-Methoxy-3-methylbenzene-1,4-diol 231 
 
 
 
To a solution of 230 (12.58 g, 66.85 mmol) in water (25 mL) and MeOH (13 mL) was 
added PIDA (32.3 g, 100.3 mmol). After stirring for 16 h at room temperature, the 
solution was treated with aq. ammonium chloride, extracted with diethyl ether (3x) 
and washed with NaHCO3. The organic layer was evaporated till approx. 100 mL. 
The solution was mixed with water (100 mL) and sodium hydrosulfite (46.55 g, 
267 mmol) was slowly added. The reaction mixture was stirred for 1 h at room 
temperature. The aqueous layer was extracted with diethyl ether (3x). The combined 
organic layers were washed with brine, dried over MgSO4, and the solvent was 
removed by rotary evaporation. The precipitate was washed with hexane to the crude 
product 231 (7.31 g, 71%) as a brown solid and was used in the next step without 
further purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.68 (d, J = 8.5 Hz, 1H), 6.48 (d, J = 8.5 Hz, 1H), 
5.18 (s, 1H), 4.32 (s, 1H), 3.78 (s, 3H), 2.20 (s, 3H). 
 
1H NMR 
 
120 
2-Methoxy-1,4-bis(methoxymethoxy)-3-methylbenzene 232 
 
 
 
To a solution of 231 (10.38 g, 67.15 mmol) in THF (330 mL) was added NaH (9.4 g, 
60% in mineral oil, 235 mmol) at 0 °C. After stirring for 1 h at room temperature, the 
suspension was cooled to 0 °C and MOMCl (20 mL, 269 mmol) was added. The 
reaction mixture was stirred for 24 h at room temperature. The suspension was 
quenched with water, extracted with diethyl ether (3x), washed with brine and dried 
over MgSO4. The solvent was removed by rotary evaporation. The residue was 
purified by column chromatography (hexane/EtOAc, 4:1) to give 232 (11.06 g, 68%) 
as clear oil. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.90 (d, J = 9.0 Hz, 1H), 6.75 (d, J = 9.0 Hz, 1H), 
5.15 (s, 2H), 5.13 (s, 2H), 3.81 (s, 3H), 3.51 (s, 3H), 3.48 (s, 3H), 2.18 (s, 3H). 
 
1H NMR 
 
121 
1-Bromo-4-methoxy-2,5-bis(methoxymethoxy)-3-methylbenzene 233 
 
 
 
To a solution of 232 (9.7 g, 40.06 mmol) in THF (130 mL) was added NBS (8.56 g, 
48.1 mmol) at 0 °C. The mixture was stirred for 16 h in the dark at 0 °C. The solution 
was quenched with sodium hyposulfite, extracted with diethyl ether (3x), washed with 
brine and dried over MgSO4. The solvent was removed by rotary evaporation. The 
residue was purified by column chromatography (hexane/EtOAc, 4:1) to give 233 
(10.04 g, 78%) as clear red oil. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 7.21 (s, 1H), 5.16 (s, 2H), 5.02 (s, 2H), 3.80 (s, 
3H), 3.64 (s, 3H), 3.51 (s, 3H), 2.27 (s, 3H). 
 
1H NMR 
 
122 
4-Methoxy-2,5-bis(methoxymethoxy)-3-methylbenzaldehyde 234 
 
 
 
To a solution of 233 (2.51 g, 7.91 mmol) in THF (26 mL) was added t-BuLi (11.6 mL, 
1.7 M solution in pentane, 19.78 mmol) under argon atmosphere at -78 °C. After 
stirring for 30 min dry DMF (3.1 mL, 40.0 mmol) was added. The reaction mixture 
was stirred for 2.5 h at -78 °C. The mixture was quenched with MeOH and warmed to 
room temperature. The resulting solution was treated with aq. ammonium chloride, 
extracted with diethyl ether (3x), washed with brine and dried over MgSO4. The 
solvent was removed by rotary evaporation. The residue was purified by column 
chromatography (hexane/EtOAc, 3:1) to give 234 (1.58 g, 74%) as clear oil. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 10.22 (s, 1H), 7.46 (s, 1H), 5.22 (s, 2H), 5.02 (s, 
2H), 3.91 (s, 3H), 3.59 (s, 3H), 3.51 (s, 3H), 2.23 (s, 3H). 
 
Ethyl 2-(diethoxyphosphoryl)acetate 203 
 
 
 
Ethyl bromoacetate (0.11 mL, 1.0 mmol) and triethyl phosphite (0.18 mL, 1.04 mmol) 
were mixed neat at room temperature. The reaction mixture was heated slowly to 
90 °C and stirred for 22 h. The resulting solution was cooled to room temperature to 
afford the crude product 203 (220 mg, 98%) as clear oil and was used in the next 
step without further purification. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 4.18 (m, 6H), 2.95 (d, J = 21.6 Hz, 2H), 1.34 (t, 
J = 7.0 Hz, 6H), 1.28 (t, J = 7.1 Hz, 3H). 
123 
(E)-Ethyl 3-(4-methoxy-2,5-bis(methoxymethoxy)-3-methylphenyl)acrylate 237 
 
 
 
To a solution of 203 (515 mg, 2.11 mmol) in THF (7 mL) was added NaH (90 mg, 
60% in mineral oil, 2.25 mmol) at 0 °C. After stirring for 15 min, 234 (190 mg, 
0.70 mmol) was added and the solution was stirred for 1 h at 0 °C. The resulting 
mixture was quenched with aq. ammonium chloride, extracted with diethyl ether (3x), 
washed with brine and dried over MgSO4. The solvent was removed by rotary 
evaporation. The residue was purified by column chromatography (hexane/EtOAc, 
4:1) to give 237 (221 mg, 92%) as a clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 7.97 (d, J = 16.1 Hz, 1H), 7.22 (s, 1H), 6.33 (d, 
J = 16.1 Hz, 1H), 5.19 (s, 2H), 4.93 (s, 2H), 4.25 (q, J = 7.2 Hz, 2H), 3.84 (s, 3H), 
3.64 (s, 3H), 3.52 (s, 3H), 2.22 (s, 3H), 1.33 (t, J = 7.0 Hz,.3H). 
 
13C NMR (100 MHz, CDCl3):  167.1, 153.3, 151.0, 147.4, 140.0, 126.5, 124.0, 
118.0, 111.8, 100.4, 95.6, 60.5, 60.4, 57.9, 56.3, 14.3, 10.2 ppm 
 
IR: 2935, 2828, 1709, 1632, 1481, 1285, 1157, 1049, 960, 858 cm-1 
 
HRMS: calculated for C17H24O7Na
+: 363.1415; found: 363.1424 
 
124 
1H NMR 
 
 
13C NMR 
 
125 
(E)-Ethyl 3-(2,5-dihydroxy-4-methoxy-3-methylphenyl)acrylate 227 
 
 
 
To a solution of 237 (27 mg, 0.07 mmol) in EtOH (0.75 mL) was added conc. HCl 
(0.08 mL, 37 wt.%). The reaction mixture was stirred for 16 h at room temperature. 
The resulting solution was neutralized with aq. NaHCO3, extracted with diethyl ether 
(3x), washed with brine and dried over MgSO4. The solvent was removed by rotary 
evaporation. The residue was purified by column chromatography (hexane/EtOAc, 
2:1) to give 227 (14 mg, 75%) of as a white solid. 
 
1H NMR (400 MHz, CD3OD):  (ppm) 8.01 (d, J = 16.1 Hz, 1H), 6.89 (s, 1H), 6.34 (d, 
J = 16.1 Hz, 1H), 4.22 (q, J = 7.1 Hz, 2H), 3.77 (s, 3H), 2.14 (s, 3H), 1.32 (t, 
J = 7.1 Hz, 3H). 
 
IR: 2922, 2851, 2360, 2340, 1719, 1634, 1468, 1275, 1193, 669 cm-1 
 
1H NMR 
 
126 
Cis-decaline 235 
 
 
 
To a suspension of 227 (14 mg, 0.056 mmol) and 1-tert-buthyldimethylsiloxypenta-
1,3-diene (229) (35 mg, 0.18 mmol, mixture of stereoisomers) in THF (0.1 mL) was 
added MnO2 (9.7 mg, 0.11 mmol) at 10 °C in one portion. The mixture was warmed 
to room temperature and stirred for 19 h, then was diluted with diethyl ether, and 
filtered through Celite. The Celite was washed thoroughly with diethyl ether, and the 
filtrate was concentrated in vacuo. The residue was purified by flash chromatography 
(hexane/EtOAc, 6:1) to give 235 (11 mg, 44%) of as a white solid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 6.88 (d, J = 16.2 Hz, 1H), 5.89 (d, J = 16.2 Hz, 
1H), 5.71 (m, 2H), 4.30 (m, 1H), 4.19 (dq, J = 6.8, 1.0 Hz, 2H), 3.97 (s, 3H), 3.09 (d, 
J = 4.8 Hz, 1H), 2.29 (m, 1H), 1.82 (s, 3H), 1.40 (d, J = 7.6 Hz, 3H), 1.29 (t, 
J = 7.2 Hz, 3H), 0.83 (t, J = 7.9 Hz, 9H), 0.44 (q, J = 8.2 Hz, 6H). 
 
13C NMR (100 MHz, CDCl3):  198.2, 192.2, 165.9, 162.8, 145.7, 133.9, 128.6, 
125.0, 123.0, 68.6, 61.0, 60.7, 59.4, 52.0, 29.1, 17.1, 14.2, 8.8, 6.5, 4.8 ppm 
 
IR: 2921, 2877, 1711, 1659, 1609, 1459, 1373, 1282, 1045, 727 cm-1 
 
HRMS: calculated for C24H36O6Na
+: 471.2174; found: 471.2179 
 
127 
1H NMR 
 
 
13C NMR 
 
128 
Tertiary allylic alcohol 238 
 
 
 
To a solution of 237 (200 mg, 0.59 mmol) in THF (4.0 mL) was added 
methylmagnesium bromide (0.78 mL, 22 wt.% solution in THF, 2.35 mmol) dropwise 
at 0 °C. After stirring at room temperature for 2 h, the resulting solution was 
quenched with aq. ammonium chloride, extracted with diethyl ether (3x), washed with 
brine and dried over MgSO4. The solvent was removed by rotary evaporation. The 
residue was purified by column chromatography (hexane/EtOAc, 1:1) to give 238 
(175 mg, 91%) as clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 7.09 (s, 1H), 6.83 (d, J = 16.1 Hz, 1H), 6.25 (d, 
J = 16.1 Hz, 1H), 5.20 (s, 2H), 4.91 (s, 2H), 3.81 (s, 3H), 3.61 (s, 3H), 3.53 (s, 3H), 
2.22 (s, 3H), 1.51 (s, 1H), 1.42 (s, 6H). 
 
13C NMR (100 MHz, CDCl3):  149.0, 148.5, 147.2, 138.0, 126.1, 126.1, 121.6, 
111.3, 99.9, 95.6, 71.2, 60.5, 57.7, 56.3, 29.9, 10.2 ppm 
 
IR: 3428, 2967, 2930, 1479, 1229, 1151, 1045, 963, 922, 855 cm-1 
 
HRMS: calculated for C17H26O6Na
+: 349.1622; found: 349.1608 
 
129 
Tertiary allylic acetate 239 
 
 
 
To a solution of 238 (140 mg, 0.44 mmol) in CH2Cl2 (4.4 mL) was added DMAP 
(5.3 mg, 0.044 mmol), acetic anhydride (0.21 mL, 2.18 mmol) and triethylamine 
(31 µL, 0.22 mmol). The reaction mixture was stirred for 20 h at room temperature. 
The resulting solution was quenched with water, extracted with diethyl ether (3x), 
washed with NaHCO3 and brine and dried over MgSO4. The solvent was removed by 
rotary evaporation. The residue was purified by column chromatography 
(hexane/EtOAc, 3:1) to give 239 (147 mg, 92%) as a clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 7.06 (s, 1H), 6.77 (d, J = 16.5 Hz, 1H), 6.31 (d, 
J = 16.3 Hz, 1H), 5.20 (s, 2H), 4.90 (s, 2H), 3.80 (s, 3H), 3.60 (s, 3H), 3.53 (s, 3H), 
2.22 (s, 3H), 2.00 (s, 3H), 1.62 (s, 6H). 
 
13C NMR (100 MHz, CDCl3):  170.0, 149.0, 148.7, 147.1, 134.4, 126.1, 126.0, 
123.3, 111.5, 99.9, 95.6, 80.7, 60.5, 57.7, 56.3, 27.0, 22.3, 10.2 ppm 
 
IR: 2922, 2852, 1739, 1666, 1593, 1481, 1230, 1152, 1045, 957 cm-1 
 
HRMS: calculated for C9H10O3Na
+: 391.1728; found: 391.1710 
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Dimethyl ester 241 
 
 
 
To a solution of Pd(OAc)2 (1.6 mg, 0.007 mmol) and triphenylphosphine (7 mg, 
0.028 mmol) in THF (0.3 mL) was added a solution of 239 (50 mg, 0.136 mmol) in 
THF (0.3 mL). In another flask, to a suspension of NaH (7 mg, 60% in mineral oil, 
0.16 mmol) was added dimethylmalonate (31 µl, 0.271 mmol) at 0 °C and stirred for 
5 min until a clear solution obtained. It was then added to the reaction mixture and 
stirred for 6 h at room temperature. It was diluted with water, extracted with diethyl 
ether (3x), washed with brine, dried over MgSO4 and concentrated under reduced 
pressure. The crude product was purified by column chromatography 
(hexane/EtOAc, 3:1) to give 241 (43 mg, 72%) as a clear liquid. 
 
1H NMR (400 MHz, CDCl3):  (ppm) 7.02 (s, 1H), 6.60 (d, J = 16.3 Hz, 1H), 6.22 (d, 
J = 16.3 Hz, 1H), 5.18 (s, 2H), 4.87 (s, 2H), 3.68 (s, 6H), 3.59 (s, 3H), 3.52 (s, 3H), 
3.44 (s, 1H), 2.20 (s, 3H), 1.33 (s, 6H). 
 
13C NMR (100 MHz, CDCl3):  168.2, 148.8, 148.4, 147.1, 137.1, 126.7, 126.0, 
122.8, 111.7, 99.8, 95.7, 60.8, 60.5, 57.7, 56.3, 52.1, 39.0, 25.4, 10.2 ppm 
 
IR: 2956, 1755, 1481, 1437, 1338, 1280, 1238, 1153, 1092, 969 cm-1 
 
HRMS: calculated for C22H32O9Na
+: 463.1939; found: 463.1925 
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7. Appendix 
 
Abstract 
 
In the last twenty years several research groups focused their attention on the 
chemically rich gorgonians (sea fans, sea whips and sea plumes) found in the reef 
habitants of the West Indian region. Especially the gorgonian octocoral 
Pseudopterogorgia elisabethae, collected from several locations throughout the 
Caribbean region, is of particular interest since chemical investigations have revealed 
these animals to contain large quantities of highly bioactive secondary terpenoid 
metabolites. For example some pseudopterosins which are diterpene-pentose-
glycosides of the amphilectane class possess high anti-inflammatory and analgesic 
properties. 
 
The unique structure and biological activity from some of these natural products 
motivated synthetic research groups to establish synthetic approaches. These efforts 
have led to many reported total synthesis of P. elisabethae diterpenes. A still 
unsolved challenge is the total synthesis of elisabethin A. Many attempts of several 
synthetic research groups were reported but none of them were able to establish a 
total synthesis of this complex molecule. 
 
This master thesis deals with the total synthesis of elisabethin A too. In contrast to 
previous published approaches we focused on an early stage Diels-Alder reaction to 
generate the decaline system with the quaternary carbon atom. Further key steps are 
the side chain introduction and the five membered ring closing reaction to the desired 
elisabethin core. 
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Zusammenfassung 
 
In den letzen zwanzig Jahren haben sich viel Forschungsgruppen mit Gorgonians 
(Korallen) aufgrund deren Vielfältigkeit an chemischen Verbindungen beschäftigt. 
Der natürliche Lebensraum dieser Korallen ist der westinidsche Ozean. Besondere 
Aufmerksamkeit erhielt dabei die Gorgonien Octocorallia Pseudopterogorgia 
Elisabethae, die an verschiedenen Orten in der Karibik vorkommt. Chemische 
Untersuchungen dieses Tieres zeigten ein breites Spektrum biologisch hochaktiver 
Terpenoide und Sekundärmetabolite. Ein Beispiel dafür sind einige Pseudopterosine, 
Diterpenoid-Pentose-Glycoside der Amphilectan Klasse, die eine sehr hohe 
entzündungshemmende und schmerzmildernde Wirkung besitzen. 
 
Die einzigartigen Strukturen und bemerkenswerten biologischen Eigenschaften jener 
Naturstoffe erweckten auch das interesse von synthetischen Forschungsgruppen. 
Dadurch entstanden viele Totalsynthesen von Diterpenen, die aus P. Elisabethae 
isoliert wurden. Ein bis heute ungelöstes Problem stellt die Totalsynthese von 
Elisabethin A dar. Viele Ansätze von verschiedenen Forschungsgruppen wurden 
unternommen um diesen komlexen Naturstoff herzustellen, doch keiner davon war 
erfolgreich. 
 
Diese Masterarbeit beschäftigt sich ebenfalls mit der Totalsynthese von Elisabethin 
A. Im Gegensatz zu anderen Totalsynthesen wählten wir eine intermolekulare Diels-
Alder Reaktion um das Grundgerüst aufzubauen. Weitere Schlüsselschritte in der 
Synthese sind die Einführung der Seitenkette und der anschließende Fünfringschluss 
zum gewünschten Elisabethingrundgerüst. 
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Possible Approach to Elisabethin A 
 
A possible total synthesis to elisabethin A (14) is outlined in Scheme 59. This route 
shows our envisioned strategy to the natural product. 
 
 
Scheme 59: Possible approach to elisabethin A (14) 
 
The first step is an intermolecular Diels-Alder reaction with in situ oxidized 
hydroquinone 154 and diene 155 which is prepared from commercially available E-2-
pentenal 158 by enolization with triethylamine and protection of the enol with 
TBSOTf. Epimerization of the resulting cis-decaline with Aluminum oxide provides 
trans-decaline 153. Reduction of the ester moiety with DIBAL and subsequent 
oxidation using IBX delivers aldehyde 250. The side chain is introduced with 
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allylmagnesium chloride. Protection of the resulting alcohol with MOMCl and 
cleavage of the TBS group with TBAF affords allylic alcohol 251. Functionalization of 
the allylic hydroxy group with phenyl chlorothionoformate generates a xanthate. A 
radical ring closing reaction with tributyltin hydride and AIBN provides the five 
membered ring. Subsequent hydrogenation of the double bond in the six membered 
ring with molecular hydrogen and palladium on charcoal affords tricyclic enedione 
252. The next reaction is conjugate addition to the enedione with lithium 
dimethylcuprate and protection of the generated enol with TMS-Cl. A subsequent 
Rubottom oxidation with mCPBA delivers alcohol 253. Cleavage of the MOM group 
with zinc bromide provides the diol. Oxidation of the alcohols with IBX and 
subsequent oxidation of the enol with methyl iodide and triethylamine delivers 
compound 150. Olefination of the ketone with a Wittig reagent provides the methyl 
enol ether. Cleavage of this ether with hydrochloric acid affords aldehyde 254. A 
further Wittig olefination generates the desired isobutenyl side chain. Cleavage of the 
methyl group with boron tribromide delivers elisabethin A (14). 
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